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In the recent few years, there have been numerous studies describing newly discovered 
cell death programs and the metabolic regulation of these cell death processes is 
poorly understood. Here we investigate two different cell death forms, ferroptosis and 
entosis, to examine how these death mechanisms are affected by conditions of 
metabolic stress. We have found that amino acid starvation can lead to ferroptosis of 
cells that have been treated with ultrasmall particles through depletion of cellular 
glutathione levels. This suggests that these ultrasmall silica nanoparticles, under 
nutrient-deprived conditions, can be utilized as inducers of ferroptosis. We have found 
that in vivo xenograft growth, which is accompanied by nutrient deprivation, was also 
inhibited with intravenous injections of these nanoparticles, suggesting the potential 
utilization of these particles as therapeutic agents to induce ferroptosis. We have also 
found that the death of live engulfed cells can be regulated by amino acids and mTOR 
activity. We find that amino acid withdrawal or mTOR inhibition induces apoptosis of 
engulfed cells and also disrupts entotic cell death that is associated with the lipidation 
of LC3 to entotic vacuoles. Cells ingested by two other live cell engulfment programs, 
homotypic cell cannibalism (HoCC) and anti-CD47 antibody-mediated phagocytosis, 
also known as phagoptosis, also undergo a similar vacuole maturation sequence 
involving LC3 lipidation and lysosome fusion, but only HoCC involves mTOR-
dependent regulation of vacuole maturation and cell death, similar to entosis. We 
further find that the regulation of apoptosis by mTOR involves the 4E-BP1 protein 
that is a known regulator of mRNA translation. The knockout of 4E-BP1 in engulfed 
cells rescues these cells from undergoing apoptosis caused by mTOR inhibition. These 
data identify amino acid signaling and the mTOR-4EBP-1 pathway as a survival 
pathway for live engulfed cells formed by entosis and HoCC. Together, my studies 
have uncovered novel roles of amino acid signaling in controlling cell death, and have 
identified, for ferroptosis, a potential new therapeutic strategy. 
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CHAPTER 1: Introduction 
 
1.1 HISTORICAL PERSPECTIVE 
 
The concept of cell death as a physiological process was first recognized in1842 by 
Carl Vogt when he made the observation that cell death was involved in removal of 
the notochord during amphibian development (Vogt, 1842). Then in 1964, more than a 
century later, Richard Lockshin and Carroll Williams observed that cell death is a 
regulated process by studying insect metamorphosis (Lockshin and Williams, 1965). 
Further progress in the field was made by using the model organism Caenorhabditis 
elegans which revealed that apoptosis, the most studied cell death form, has a 
genetically defined program and its biochemical mechanisms are conserved in various 
animal systems (Ellis and Horvitz, 1986). For many following years, apoptosis was 
considered to be the only major form of programmed cell death and was the focus of 
numerous studies that lead to many significant findings. Recently, however, an 
expanding number of new studies have revealed that there are many other diverse 
forms of non-apoptotic cell death programs that occur in various contexts. Most of 
these cell death forms occur in an active manner, as a consequence of distinct 
signaling events to specific stimuli. Dysregulation of cell death signaling is involved 
in various pathological conditions such as cancer, autoimmune, and neurodegenerative 
diseases. In particular, cancer cells have been shown to evade cell death and this is 
recognized as one of the hallmarks of cancer development (Hanahan and Weinberg, 
2011). Another hallmark of cancer that is emerging as a focus of numerous studies is 
the reprogramming of metabolic pathways. Although some results suggest that 
metabolism and cell death are linked, they are mostly focused on the regulation of 
apoptosis. It will be important to learn how metabolic changes can induce or regulate 
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other non-apoptotic cell death forms in various contexts. In the following sections, I 
will introduce the characteristics of regulated cell death programs with a focus on non-
apoptotic cell death forms, and discuss how cell death processes can be regulated by 
metabolic stress. 
 
1.2 CELL DEATH FORMS 
 
It is now well accepted that programmed cell death is required for normal tissue 
development and homeostasis of organisms. Cell death supports the development of 
various tissues as well as the turnover of aged cells or unwanted immune cells (Lee et 
al., 2002; Lindsten et al., 2000; Rathmell et al., 2002). Cell death is also relevant in the 
context of pathological processes such as degenerative diseases and cancer, and has 
been recognized as an important barrier to tumor development. Classically, 
mammalian cell death programs are categorized into three major types of 
morphologically distinct cell death forms: apoptosis (type 1), autophagic cell death 
(type II), and necrosis (type III) (Schweichel, 1973). 
 
1.2.1 Apoptosis 
Apoptosis has been the main focus of the cell death field for several decades and its 
molecular mechanism and clinical applications have been well studied (Fulda, 2015; 
Korsmeyer, 1992; Wong, 2011). Morphologically, apoptosis is characterized by cell 
shrinkage, membrane blebbing, condensation of chromatin, and cell and nuclear 
fragmentation that leads to the formation of apoptotic bodies (Xiong et al., 2014). 
Apoptosis can be triggered when cell-surface death receptors such as Fas are bound by 
their ligands (extrinsic pathway) or when the pro-apoptotic Bcl-2 (B-cell lymphoma 2) 
family proteins cause permeabilization of the mitochondrial outer membrane (intrinsic 
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pathway). Both pathways converge on the activation of caspase proteases, which are 
ultimately responsible for the dismantling of the cell. Deficiencies for key caspases of 
the apoptotic pathway cause pre- or neonatal lethality due to impaired organ 
development demonstrating the importance of apoptosis during embryonic 
development (Hakem et al., 1998; Kuida et al., 1996). Apoptosis can influence tumor 
progression in multiple ways as oncogenic alterations that disrupt apoptosis (e.g. Bcl-2 
translocation, mutation of phosphatidylinositol-3-kinase (PI3K) catalytic subunit 
p110α) can lead to cancer development, but conversely other oncogenic changes (e.g. 
c-Myc amplification) can promote apoptosis (Korsmeyer, 1992; McDonnell et al., 
1989). Further research of signaling pathways and molecular mechanisms leading to 
apoptosis in specific contexts will provide new avenues for cancer therapy.  
 
1.2.2 Autophagic cell death 
Autophagy is a catabolic process in which parts of the cytosol and specific organelles 
are engulfed by a double membrane structure, known as the autophagosome, and 
eventually degraded inside lysosomes to be recycled. The autophagy pathway is 
induced when cells are deprived of nutrients or when cells are under conditions of 
stress. Although autophagy mostly acts as a survival mechanism, there are a few 
examples of autophagy functioning as a death mechanism, (hence the term 
“autophagic cell death”), where components of the autophagic signaling pathway 
actively promote cell death. During Drosophila metamorphosis, involution of the 
midgut and salivary glands involves massive autophagy-induced cell death triggered 
by the steroid hormone ecdysone (Berry and Baehrecke, 2007; Denton et al., 2009). In 
this scenario, a deficiency in autophagy-related (ATG) genes, which are required for 
the autophagy protein microtubule-associated protein 1A light chain 3 (LC3) 
lipidation and elongation of autophagosomal membranes, inhibits cell death. Also, 
	   4	  
forced expression of ATG1, which is a component of the upstream initiation complex 
needed for the induction of the autophagy pathway, is sufficient to promote cell death 
in this context (Scott et al., 2007). Despite this clear genetic evidence for a pro-death 
function of autophagy in development, a mechanistic link between the formation of 
autophagosomes and the execution of cell death, to explain how autophagy can kill 
cells, has remained lacking. A recent study has suggested that autophagic cell death 
also occurs in mammalian cells and involves activity of the plasma membrane Na+/K+-
ATPase (Liu et al., 2013), but it remains controversial whether autophagic cell death 
contributes to development and disease in humans. 
 
1.2.3 Necrosis 
Although necrosis was thought for a long time to be an accidental process that 
occurred in response to physiochemical insults, it has become evident in the past few 
years that necrosis can be initiated and executed in a regulated and genetically 
controlled manner (Degterev et al., 2008; Degterev et al., 2005). This relatively recent 
finding has spawned a new generation of research into many non-apoptotic cell death 
mechanisms. Necrosis is morphologically characterized by cell swelling and rapid 
plasma membrane rupture, and a loss of organelle structure without chromatin 
condensation. The best-characterized form of programmed necrosis is RIP-dependent 
necrosis, referred to as necroptosis, which requires the kinase activity of RIP1 and 
RIP3. Necroptosis can be initiated from tumor necrosis factor receptor 1 (TNFR1) 
ligation, which is followed by the recruitment and activation of RIP3 by RIP1. 
Phosphorylation of RIP3 triggers oligomerization of the pseudokinase mixed lineage 
kinase-like (MLKL) and translocation to the plasma membrane, which leads to a 
disruption in ionic homeostasis and cell rupture (Sun et al., 2012). Although RIP3 or 
MLKL deficiency does not lead to defects in development or adulthood (Newton et 
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al., 2004; Wu et al., 2013), RIP3-deficient mice die after challenge with vaccinia virus, 
highlighting the physiological relevance of necroptosis as a viral defense mechanism 
(Cho et al., 2009; Wu et al., 2013). 
 Aside from necroptosis, there has been an expansion of other regulated 
necrotic death forms that are consistent with the morphological definition of necrosis, 
but are independent of RIP1 or RIP3 activity. Ferroptosis, one of these additional 
necrotic cell death forms, was discovered several years ago and has been the topic of 
numerous recent studies. It was shown by initial studies that RAS-transformed cells 
treated with a lethal small molecule called erastin undergo regulated necrosis, 
resulting from inhibition of the system XC-Cys/Glu antiporter that is required for 
generation of the key antioxidant glutathione (GSH) (Dixon et al., 2012). This type of 
cell death was named ferroptosis because it also crucially depends on intracellular 
iron, perhaps to support, through Fenton chemistry, the accumulation of lethal reactive 
oxygen species (ROS). GSH peroxidase 4 (GPX4) has been shown to be an important 
enzyme that defends cells against ferroptosis by scavenging lipid peroxides, and its 
activity relies on cellular GSH levels (Yang et al., 2014). Therefore, GSH depletion 
typically leads to loss of GPX4 function, resulting in ROS-mediated lipid 
peroxidation. This is most likely similar to the cell death process named oxytosis in 
which neuronal cells die through the inhibition of the XC-Cys/Glu antiporter by excess 
glutamate-induced excitotoxicity (Tan et al., 2001).  
 In addition to necroptosis and ferroptosis, still additional forms of regulated 
necrosis have also emerged, including cyclophilin D (CypD)-dependent necrosis, 
pyroptosis, NETosis, and parthanatos. Ischemia/reperfusion injury (I/R) leads to cell 
death caused by mitochondrial permeability transition (mPT) in which CypD plays an 
active role (Baines et al., 2005). Pyroptosis is a caspase 1-dependent death of 
macrophages in response to pathogens that leads to inflammation (Fink and Cookson, 
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2006). NETosis is a NADPH oxidase (NOX)-induced cell death of neutrophils that 
acts as an antibacterial immune defense mechanism (Remijsen et al., 2011), and 
Parthanatos is caused by overactivation of PARP1, an ADP-ribosyl transferase 
enzyme, that leads to NAD+ depletion and, consequently, cell death (Andrabi et al., 
2008).  
 
1.2.4 Engulfment-dependent cell death 
While three morphological categories of cell death have proven to be useful 
descriptors historically, it has now become evident that a much broader spectrum is 
needed to define the myriad metazoan cell death mechanisms that have recently been 
discovered (Galluzzi et al., 2015). Among numerous cell death forms that do not fit 
neatly into the historical categories, several cell death processes have been identified 
that share a common characteristic: they require the involvement of engulfing cells for 
cell death execution. This unique feature suggests that some metazoan cell deaths are 
not executed as cell suicides, but rather as cell murders, as they are triggered in a non-
cell-autonomous manner by engulfing cells. One of these mechanisms, called entosis, 
involves the engulfment and death of mammary epithelial cells and can be observed in 
breast tumors (Overholtzer et al., 2007). Engulfment by entosis is controlled by 
cadherin cell adhesion proteins and Rho-mediated cytoskeletal tension, where cells 
with high mechanical tension are engulfed by neighbors with lower tension. Ingested 
cells are then killed by a mechanism involving lipidation of the autophagy protein LC3 
onto entotic vacuoles, leading to lysosome fusion and engulfed cell death and 
degradation (Florey et al., 2011).  
Intriguingly, engulfed entotic cells can actually survive inside of their hosts for 
extended periods before being killed (from hours to more than a day), and they can 
also escape from their hosts altogether, suggesting that the decision to initiate cell 
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death is made not before, but after, engulfment. Engulfed cells residing inside their 
hosts appear to be deprived of growth factors and nutrients from media, and 
subsequently activate autophagy that supports cell survival, as a block of autophagy 
induces apoptosis (Florey et al., 2011). Thus, autophagy machinery functions during 
entosis both to promote cell survival, by acting within engulfed cells, and also to 
promote cell death by modifying entotic vacuoles within engulfing cells.  
The engulfment mechanism that initiates entosis can be induced in breast 
cancer cells by expression of E- or P-cadherin, which suppresses transformed growth 
in soft agar, suggesting that entosis may have a tumor-suppressive role (Sun et al., 
2014). On the contrary, entosis can also induce aneuploidy within host cells, which is 
known to promote tumor progression (Krajcovic et al., 2011). In addition, host cells 
can recover nutrients from degraded engulfed cells and support proliferation and 
survival in starved conditions (Krajcovic et al., 2013), suggesting that on balance, 
while entosis acts as a mechanism of cell death that can suppress transformed growth, 
it may in fact promote tumor progression in the long-term.    
Other examples of live engulfment programs include emperitosis, suicidal 
emperipolesis, phagoptosis, and homotypic cell cannbalism (HoCC). Emperitosis 
refers to the apoptotic death of engulfed natural killer cells in tumor cells caused by 
the secretion of granzyme B (Wang et al., 2013). Suicidal emperipolesis involves the 
clearance of autoreactive T cells by invasion into the liver in vivo (Benseler et al., 
2011). Phagoptosis involves the engulfment and death of cells that have 
downregulated “don’t-eat-me” signals, such as CD47, by macrophages and is being 
considered for potential therapeutic applications (Brown and Neher, 2012; 
Vonderheide, 2015). HoCC is a form of cell engulfment observed in pancreatic tumors 
and found to inversely correlate with metastasis (Cano et al., 2012).  
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1.3 REGULATION OF CELL DEATH BY AMINO ACID METABOLISM 
 
It has become clear in recent years that the regulation of cell death and metabolism are 
closely connected with multiple layers of interplay (Green et al., 2014). One classic 
example of crosstalk between metabolism and cell death is mitochondria, which 
mediate energy production in cells and also act as key inducers of apoptosis. Similarly, 
numerous metabolic intermediates (e.g. adenosine triphosphate (ATP), reactive 
oxygen species (ROS), acetyl-coenzyme (CoA), etc.) have been shown to influence 
the regulation of cell death. Understanding how metabolism affects specific cell death 
mechanisms, particularly in disease states, such as cancer, may reveal novel controls 
over disease progression, and could also lead to the identification of new therapeutic 
opportunities. Cancer cells are known to experience chronic metabolic stress, unlike 
normal cells, and undergo metabolic reprogramming to support their increased 
biosynthetic and energy demands for continued proliferation. Metabolic stress in 
cancers arises not only due to the effects of mutations to tumor suppressors and 
oncogenes that disrupt normal metabolism (e.g. p53 and Kras mutations), but also 
many solid tumors (e.g. pancreatic and breast carcinoma) experience chronically 
limited blood supplies due to insufficient vascularization. This leads to low 
availability of key nutrients (glucose, amino acids, and oxygen) for cells that are 
driven to be metabolically active by loss of normal cellular homeostatic controls. 
These specific nutrient deficiencies can have severe effects on cells that can trigger 
cell death, and may represent an Achilles’ heel that could be exploited for cancer 
therapy. In particular, recent studies have revealed that amino acids are essential to 
support the high metabolic demands of tumors and can also function as nutrient 
signals that regulate signaling pathways leading to cell survival or death. Thus, amino 
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acid availability can influence cell death regulation in a complex manner either 
through signaling or by more direct requirements to support cell metabolism.  
 
1.3.1 mTOR pathway 
Amino acid levels are sensed by cells through two major adaptive pathways, the 
mammalian target of rapamycin complex 1 (mTORC1) pathway, and the general 
control nonderepressible 2 (GCN2) pathway. The mTOR complex 1 (mTORC1) is a 
serine/threonine kinase complex that senses amino acid availability to control mRNA 
translation and autophagy. mTORC1 is scaffolded to the surface of lysosomal 
membranes, where it senses the presence of particular amino acids such as leucine, 
glutamine, and arginine, as well as energy availability (through AMPK regulation) and 
growth factor signaling, and integrates these nutrient signals to suppress autophagy 
and promote translation when nutrients are plentiful. mTORC1 signaling has been 
shown to influence multiple cell death pathways in a complex manner. Apoptosis is 
inhibited by the mTORC1-dependent the translation of mRNAs that encode key anti-
apoptotic proteins, such as myeloid cell leukemia 1 (MCL-1), and cellular FLICE-like 
inhibitory protein (cFLIP) (Meynet et al., 2013; Munoz-Pinedo et al., 2003). MCL-1 
functions to bind and inhibit the pro-apoptotic proteins Bcl-2-associated X (Bax) and 
Bcl-2 homologous antagonist/killer (Bak), and cFLIP functions to block caspase-8 or 
prevent death-inducing signaling complex (DISC) formation. As the ratio of anti-
apoptotic to pro-apoptotic Bcl-2 family proteins can regulate apoptosis sensitivity, the 
loss of MCL-1 or cFLIP expression in amino acid-starved cells with decreased 
mTORC1 activity can induce apoptosis. In addition to modulating apoptosis 
senstitivity, mTORC1 is also implicated in regulating necroptosis, in this case by 
promoting the necroptotic cell death of neuronal cells in response to TNF-α signaling. 
The inhibition of mTOR or Akt, an upstream regulator of mTOR, blocked necroptosis 
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without affecting the RIP1-RIP3 complex assembly, suggesting a role for Akt and 
mTOR downstream of RIP1 activation in regulating necroptosis (Liu et al., 2014).  
 
1.3.2 GCN2 pathway 
Another pathway that functions as an adaptive mechanism to fluctuating amino acid 
levels is the GCN2 pathway that regulates mRNA translation initiation and lipid 
metabolism, by detecting uncharged tRNAs that accumulate in the absence of amino 
acids. When activated, GCN2, a serine/threonine kinase, can phosphorylate eukaryotic 
translation initiation factor 2α (eIF2α), resulting in reduced rates of translation 
initiation and a decline in protein synthesis. While phosphorylated eIF2α generally 
suppresses protein synthesis, it can also promote translation of specific mRNAs that 
contain unique 5’ untranslated regions (UTR), such as the activating transcription 
factor 4 (ATF4) (Harding et al., 2000). ATF4 can then induce expression of many 
genes involved in amino acid metabolism, such as amino acid synthetases, 
transporters, and amino acyl tRNA synthetases (Baird and Wek, 2012; Ye et al., 
2010). ATF4 is overexpressed in several human tumor tissues and is upregulated in 
response to hypoxic stress. As ATF4 is a critical regulator of genes involved in amino 
acid metabolism, cells that have been depleted of ATF4 cannot survive or proliferate 
in the absence of non-essential amino acids (NEAAs). Likewise, the GCN2-ATF4 
pathway has been shown to be important for the survival of c-Myc-overexpressing 
neuroblastoma cells under conditions of glutamine deprivation (Qing et al., 2013). 
Sestrin2, a stress response protein that is upregulated through GCN2 signaling, was 
shown to be essential for keeping cells from undergoing apoptosis in response to 
glutamine starvation (Ye et al., 2015). 
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1.3.3 Glutamine 
Among the twenty-two standard amino acids, nine are considered to be “essential” 
because they must be obtained through nutritional intake. However, some cells, such 
as cancer cells, may conditionally depend on different amino acids based on 
microenvironmental context or genetic mutations. Several amino acids have been 
shown to be required for the survival of cancer cells due to particular metabolic 
requirements. For example, deprivation of glutamine has been shown to be 
synthetically lethal toward cancer cells with loss-of-function of p53 (Reid et al., 2013). 
Glutamine is a critical nutrient for cancer cells as a carbon and nitrogen source for 
macromolecule synthesis, an ATP source through conversion to α-ketoglutarate, and 
glutamate source for GSH synthesis. The concentration gradient of glutamine can also 
drive specific antiporters expressed at the plasma membrane to uptake other amino 
acids. Cancer cells consume glutamine to a degree that exceeds their need for the 
molecules in anabolic macromolecular synthesis and glutamine metabolism is highly 
regulated by several factors such as c-Myc, Ras, p53 and HIF. p53 can increase 
expression of the mitochondrial isoform of glutaminase (GLS2), which converts 
glutamine to glutamate, leading to enhanced mitochondrial respiration and ATP 
generation along with reduction in ROS due to increased glutathione levels (Hu et al., 
2010). Likewise, expression of c-Myc in mouse embryonic fibroblasts leads to 
induction of GLS1 along with lactate dehydrogenase and glutamine transporters, 
suggesting that c-Myc is sufficient to drive cellular dependence on glutamine (Chen 
and Cui, 2015). Therefore, not surprisingly, inhibitors of GLS, such as BPTES and 
968, have been shown to induce the cell death of cancer cells (Li et al., 2015; Simpson 
et al., 2012). Glutamine deprivation has also been reported to sensitize cells to Fas 
ligand, TNF-α, and heat shock-mediated apoptosis (Ko et al., 2001), and to induce 
apoptosis through reduction of GSH, the main antioxidant in cells. Glutamate, an 
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essential component of GSH, is mostly derived from glutamine uptake by cells and is 
necessary for cystine uptake through the XC-Cys/Glu antiporter. Glutamine 
deprivation-induced apoptosis can be reversed by inhibition of ROS production 
highlighting the importance of ROS production during apoptosis (Reid et al., 2013). 
 
1.3.4 Asparagine 
As mentioned above, glutamine deprivation can lead to cell death and this was initially 
thought to be caused by the role of glutamine to replenish tricarboxylic acid (TCA) 
cycle intermediates and support synthesis of nucleotides and non-essential amino 
acids. However, a recent study has shown that cell death induced by glutamine 
deprivation was prevented by suppression of citrate synthase, the first tricarbosylic 
acid cycle enzyme (Zhang et al., 2014). In the absence of glutamine, citrate synthase 
depletion lead to the synthesis of aspartate and asparagine and it was further shown 
that addition of asparagine was sufficient to prevent glutamine-deprivation-induced 
death. In support of this model, knockdown of asparagine synthetase (ASNS), the 
enzyme that generates asparagine, induced apoptosis even in the presence of 
glutamine, highlighting the importance of asparagine. The anti-apoptotic function of 
asparagine was dependent on its ability to suppress C/EBP-homologous protein 
(CHOP), a pro-apoptotic regulator of the unfolded protein response, without affecting 
induction of ASNS by the GCN2-ATF4 pathway. Some cancers that lack ASNS 
depend on extracellular asparagine for survival (Galluzzi et al., 2013) and use of 
asparaginase, which hydrolyzes extracellular asparagine, in patients with acute 
lymphoblastic leukemia has shown successful results (Avramis and Panosyan, 2012). 
Recently, upregulated ASNS was associated with aggressiveness in ovarian, prostate, 
and pancreatic cancers, suggesting that asparaginase may also hold therapeutic 
potential in these contexts (Panosyan et al., 2014). 
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1.3.5 Arginine 
The amino acid arginine is an important precursor for the synthesis of protein, urea, 
creatine, and nitric oxide. The enzyme that generates arginine, arginino-succinate 
synthase 1 (ASS1), is lacking in some cancers, rendering them to be dependent on 
exogenous supplies of arginine for survival (Galluzzi et al., 2013). For example, 
osteosarcoma and bladder cancer cell lines expressing low levels of ASS1 fail to grow 
in an arginine-free medium, suggesting that ASS1 may be a good target for therpeutic 
agents (Allen et al., 2014; Kobayashi et al., 2010). It has been shown that arginine 
depletion induces Bax conformation changes and mitochondrial inner membrane 
depolarization in ASS1-negative cells, which leads to apoptosis in mesothelioma cells 
(Szlosarek et al., 2006). Ongoing research of arginine deprivation therapy has led to 
the development of arginine depleters, such as pegylated arginine deiminase that may 
represent a potential treatment method for various cancers. The treatment of ASS1-
deficient prostate cell lines with these pegylated arginine deiminase resulted in cell 
death resembling an autophagic mechanism, suggesting that although some cancers 
have a common requirement for arginine metabolism, they may undergo different 
types of cell death in response to arginine depletion (Changou et al., 2014).  
 
1.3.6 Serine & Glycine 
The amino acids serine and glycine are interconvertible and interconnected via the 
glycine cleavage system, a major metabolic pathway in one-carbon metabolism that 
provides cofactors for nucleotide synthesis for proliferating cancer cells. The 
overexpression of several enzymes that function in serine and glycine metabolism can 
promote oncogenic transformation of breast and lung cancer, respectively, suggesting 
that serine and glycine metabolism can promote the growth of some cancers 
(Possemato et al., 2011; Zhang et al., 2012). Similarly, the removal of these amino 
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acids by dietary restriction was shown to limit tumor growth without impacting animal 
health (Maddocks et al., 2013). When cells are deprived of serine or glycine, the 
enzymes of the serine-glycine metabolism pathway accumulate and stabilize p53, 
resulting in the activation of multiple genes, including cyclin-dependent kinase 
inhibitor 1A (CDKN1A), coding for the cell cycle inhibitor p21Cip1 (Maddocks et al., 
2013). In the case of some cancers where p53 functions are compromised, cells 
succumb to serine-glycine deprivation, similarly to glutamine deprivation, suggesting 
that p53 has a role of suppressing cell death in this scenario (Maddocks et al., 2013; 
Reid et al., 2013).  
Some cancer cells have an increased capacity for de novo serine synthesis via 
the phosphoglycerate dehydrogenase (PHGDH) pathway. PHGDH converts the 
glycolytic intermediate 3-phosphogycerate to yield serine following a three-step 
enzymatic reaction. Suppression of PHGDH in cell lines with elevated PHGDH 
expression causes a decrease in reduction of serine synthesis and cell proliferation 
(Locasale et al., 2011). In addition, serine hydroxymethyl transferase (SHMT), the 
enzyme that converts serine to glycine, has also been implicated in tumorigenesis. The 
two isoforms of SHMT have been described as targets of c-Myc and have been shown 
to rescue the growth defects of cells depleted for c-Myc (Nikiforov et al., 2002). These 
metabolic enzymes are the focus of several clinical studies to test the efficacy of 
targeting the serine-glycine metabolic pathway for anti-tumor therapies. 
 
1.3.7 Cystine & Cysteine 
Redox control of cell death has attracted increasing interest in recent years and the 
metabolism of glutathione (GSH), the most abundant cellular antioxidant, has emerged 
as a possible target for development of anti-cancer treatments. Cysteine, typically 
present in its oxidized form cystine in the extracellular space, is regarded as the rate-
	   15	  
limiting substrate for GSH synthesis. Cystine, the predominant form in plasma, 
extracellular body fluids and cell culture medium, is transported into cells by the 
amino acid system XC-Cys/Glu antiporter. Recently, the XC-Cys/Glu antiporter has 
been shown to play an important role in promoting cell survival by blocking the 
induction of ferroptosis, as inhibition of the antiporter by excessive glutamate or 
erastin treatment can induce ferroptosis of cells (Albrecht et al., 2010; Dixon et al., 
2012). Similar results have been observed for cancer cells and several clinically 
approved drugs, such as sulfasalazine, sorafenib, and artesunate, which have been 
shown to induce ferroptosis in various types of cancer cells (Dixon et al., 2014; Eling 
et al., 2015; Louandre et al., 2015). 
 Amino acids in general can provide reducing equivalents to increase the 
cellular capacity for redox homeostasis, and deprivation of amino acids has been 
shown to lead to an accumulation of ROS, most likely through mitochondrial 
dysregulation (Chen et al., 2009). ROS have been implicated in controlling not only in 
the execution of cell death but also to the signal transduction pathways leading to the 
initiation of cell death (Trachootham et al., 2008). ROS can be generated from both 
intracellular and extracellular sources, and there are multiple cellular defense 
mechanisms, including GSH, superoxide dismutases (SODs), GPXs, and catalases. 
The mitochondria are a major source of ROS, especially superoxide anion (O2•-) and 
hydrogen peroxide (H2O2), which are normally cleared by SODs. In the cytoplasm, 
ROS may be generated from the arachidonic acid pathway or cytochrome P-450 
isozymes, which can be scavenged by GSH. In addition to these intracellular sources, 
many other extracellular agents may contribute to the formation of ROS in cells. 
Several cytotoxic agents induce ROS, such as H2O2 and O2•-, which are involved in 
the induction of apoptosis (Gorman et al., 1997). H2O2 can promote cytochrome c 
release from mitochondria upon activation of the intrinsic pathway of apoptosis, and 
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can also activate transcription factors that upregulate death proteins or inhibitors of 
survival proteins (Meyer et al., 1993). H2O2 can also upregulate Fas-FasL, leading to 
caspase activation. Also, nitric oxide (NO•) has been shown to inactivate antioxidant 
enzymes such as superoxide dismutases, GPXs, and catalase, as well as induce 
apoptosis by activating caspase-3 and the Fas system (Bosca and Hortelano, 1999; 
Dobashi et al., 1997). 
 
1.4 THESIS AIMS 
While apoptosis has been the most studied form of cell death for the past several 
decades, in the recent few years, there have been numerous studies describing non-
apoptotic cell death programs, including ferroptosis and entosis. These new 
mechanisms may also contribute to organismal homeostasis and pathophysiology, yet 
their roles in vivo remain unclear. Similarly the molecular mechanisms that regulate 
these forms of cell death remain poorly understood. My thesis aims were to investigate 
two different cell death forms, ferroptosis and entosis, to examine how these death 
mechanisms are affected by conditions of metabolic stress. My studies have uncovered 
novel roles of amino acid signaling in controlling cell death, and have identified, for 
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CHAPTER 2: Ultrasmall nanoparticle treatment induces ferroptosis  




As discussed in chapter one, ferroptosis is a recently identified non-apoptotic cell 
death mechanism that is induced by oxidative stress. Ferroptosis is triggered by 
inhibition of the system XC-Cys/Glu antiporter, or following direct inhibition of 
glutathione (GSH) peroxidase 4 (GPX4), leading to a decreased capacity to resist 
oxidative stress. Ferroptosis has been implicated in several pathological processes, 
such as neurodegeneration, acute renal failure, ischemia/reperfusion injury, immunity, 
and cancer (Xie et al., 2016). In cancer, ferroptosis has been shown to contribute to 
p53-mediated tumor suppression activity (Jiang et al., 2015), due to p53-mediated 
repression of the expression of the system XC-Cys/Glu antiporter gene SLC7A11. 
Ferroptosis may also be induced in cancers as a result of deprivation for amino acids 
due to poor vascularization, resulting in depletion of GSH. Deprivation of cystine, or 
amino acids in general, has been shown to induce ferroptosis in some contexts in 
cultured cells (Gao et al., 2015; Hayano et al., 2015). Whether potential ferroptosis-
inducing agents could synergize with amino acid deprivation to induce cancer cell 
death in vivo is an important open question. 
An approach that is receiving increasing attention for the therapeutic targeting 
of cancer is treatment with various nano-sized materials that can be targeted to tumor 
sites. Cancer-targeted nanoparticles can be used to deliver therapeutic compounds, and 
can be modified with fluorescent or radioactive tracers to be used as imaging agents to 
detect cancer lesions (Davis et al., 2008; Duncan and Gaspar, 2011; Duncan and 
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Richardson, 2012; Phillips et al., 2014). While nanoparticle-based targeting of cancer 
is receiving increasing attention, there remains relatively little understood about how 
particles of different chemistries, as well as sizes and shapes, might be best designed 
to achieve proper targeting and therapeutic efficacy (Chen et al., 2014; Li et al., 2009; 
Li et al., 2010; Ma et al., 2011; Stern et al., 2012). Here we investigated the effects of 
the delivery of ultrasmall (~6 nm diameter) poly(ethylene glycol) (PEG)-coated silica 
nanoparticles, functionalized with melanoma-targeting peptides, into cells and tumors 
in vivo. These particles, called Cornell dots or C’ dots, are currently in clinical trials 
for use as imaging agents for the detection of cancer. We examined the effects of 
particle loading on cell viability under conditions of increasing dosage and nutrient 
deprivation. Remarkably, we discovered that C’ dot nanoparticle treatment induces 
ferroptosis when cells are also starved for amino acids. Moreover, intravenous particle 
delivery to tumor-bearing mice leads to tumor regression in a ferroptosis-dependent 
manner. These data identify ultrasmall silica nanoparticles, utilized under nutrient-
deprived conditions, as novel inducers of ferroptosis. 
 
2.2 MATERIALS AND METHODS 
 
2.2.1 Cell culture and constructs 
MEF and HT1080 cells (American Type Culture Collection (ATCC)) were cultured in 
Dulbecco's modified Eagle's medium (DMEM) (MSKCC Media Preparation Facility) 
supplemented with 10% fetal bovine serum (FBS, Sigma, St. Louis, MO) with 
penicillin/streptomycin (Corning, Corning, NY). MCF10A cells (ATCC) were 
cultured in DMEM/F12 (Gibco, Grand Island, NY) supplemented with 5% horse 
serum (Atlanta Biologicals, Flowery Branch, GA), 20 ng/ml EGF (Peprotech, Rocky 
Hill, NJ), 10 µg/ml insulin (Sigma), 0.5 µg/ml hydrocortisone (Sigma), and 100 ng/ml 
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cholera toxin (Sigma) with penicillin/streptomycin. M21, BxPC3 (ATCC), and H1650 
cells were cultured in RPMI-1640 (Gibco) supplemented with 10% FBS with 
penicillin/streptomycin. Cells were routinely verified as mycoplasma-free by DAPI 
imaging. Amino acid-free medium was prepared by dialyzing heat-inactivated FBS 
(for MEF, HT1080, M21, BxPC3, and H1650 cells) or horse serum (for MCF10A 
cells) for 4 h, followed by overnight incubation at 4°C in phosphate-buffered saline 
(PBS) in MWCO 3500 dialysis tubing (21-152-9; Fisherbrand, Pittsburgh, PA) and 
addition to base media prepared without amino acids. pRetro–Lamp1–GFP was 
introduced into M21 cells by retroviral transduction, and stable cell lines were selected 
with puromycin (2 µg/ml). 
 
2.2.2 Reagents 
The following reagents were used at the indicated concentrations: Concanamycin A 
(ConA) (Sigma) 100 nM; SYTOX Green Nucleic Acid Stain (S7020; Invitrogen, 
Carlsbad, CA) 5 nM; Ferrostatin-1 (Fer-1) (EMD Millipore, Billerica, MA) 1 µM; 
Deferoxamine (DFO) (Sigma) 100 µM; Butylated hydroxyanisole (BHA) (Sigma) 50 
µM; Ascorbic acid (AA) (Sigma) 200 µM; Trolox (Sigma) 100 µM; N-acetylcysteine 
(NAC) (Sigma) 10 mM; Glutathione (GSH) (Sigma) 5 mM; TNFα (Sigma) 100 ng/ml; 
Cycloheximide (CHX) (Sigma) 1 µg/ml and 50 µg/ml to induce necroptosis and 
apoptosis, respectively; zVAD (Sigma) 20 µM; Necrostatin-1 (Sigma) 30 µM; 
Buthionine sulphoximine (BSO) (Sigma) 400 µM. Reagents were added to cultures at 
the start of biological assays with the exception of ConA which was added 1 hour 
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2.2.3 Peptide synthesis 
A modified melanocortin-1 receptor targeting peptide Re(Arg11)CCMSH (Miao et al., 
2007) with a double aminohexanoic acid (Ahx2) aliphatic linker and N-Ac-Cys was 
synthesized using standard solid phase Fmoc peptide chemistry. The rhenium-cyclized 
αMSH peptide analog, Ac-Cys1-(Ahx)2-dLys2-Re[Cys-Cys-Glu-His-dPhe-Arg-Trp-
Cys]-Arg-Pro-Val-NH2, was analyzed and purified on a Beckman Coulter High 
Performance Liquid Chromatography (HPLC) system coupled with an LCQ FLEET 
Ion Trap Mass spectrometer (Thermo Fisher Scientific) and finally recovered by 
lyophilization.  
 
2.2.4 Synthesis and characterization of αMSH-PEG-C’ dots 
Fluorescent silica nanoparticles (C’ dots), encapsulating the organic dye, Cy5, were 
synthesized in water as previously described (Ma et al., 2015). αMSH peptides were 
conjugated to maleimido-terminated heterobifunctional polyethylene glycol silane 
(mal-PEG-silane) via its N-terminal acetylated cysteine thiol to form αMSH-PEG-
silane. Conjugates were attached to the particle surface in the PEGylation step to 
generate αMSH functionalized C' dots, or αMSH-PEG-C’ dots. Synthesized particle 
samples were dialyzed in water and purified by gel permeation chromatography (GPC, 
Bio-Rad Laboratories, Inc, Hercules, California) prior to further characterization. 
Absorption and emission spectral profiles for the encapsulated and native Cy5 dye 
were obtained using a Varian Cary 5000 spectrophotometer (Varian, Palo Alto, CA) 
and a fluorescence spectrofluorometer (Photon Technology International, Inc, 
Birmington, NJ). Hydrodynamic radius, brightness, and concentration of αMSH-PEG-
C’ dots, as against free Cy5 dye, were determined using a homebuilt fluorescence 
correlation spectroscopy (FCS) set up configured with a solid-state 633-nm excitation 
(Sadasivan et al., 1998).  
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2.2.5 Western blotting 
Cells were scraped into ice-cold RIPA buffer (50 mM Tris at pH 7.4, 150 mM NaCl, 2 
mM EDTA, 1% NP40, 0.1% SDS with protease inhibitor cocktail) and lysed for 10 
min on ice. Lysates were then centrifuged at 15,870g for 20 min at 4 °C and protein 
was quantified by BCA assay (Pierce, Waltham, MA). Samples were separated on 
15% polyacrylamide SDS–PAGE gels and transferred to a polyvinyldifluoride 
membrane which was blocked with TBST plus 5% BSA and incubated overnight at 4 
°C with primary antibodies (anti-LC3A/B (4108; Cell Signaling, Danvers, MA) and 
anti-Actin (A1978; Sigma)), diluted in blocking buffer. Blots were incubated with 
horseradish peroxidase conjugated to secondary antibodies and protein was detected 
using enhanced chemiluminescence detection (Invitrogen). Densitometry analysis was 
carried out using ImageJ software (NIH). 
 
2.2.6 Time-lapse microscopy 
Cells were plated onto glass-bottom dishes (MatTek, Ashland, MA) overnight and 
fluorescence and differential interference contrast (DIC) images were acquired every 
30 min for indicated times using a Nikon TI-E inverted microscope, a CoolSNAP HQ2 
CCD (charge-coupled device) camera (Photometrics, Tucson, AZ), a live-cell 
incubation chamber to maintain cells at 37 °C and 5% CO2, and NIS Elements 
software (Nikon, Melville, NY). Cell fates, including cell survival, death, and 
proliferation, were manually quantified and processed using NIS Elements software 
and Image J. 
 
2.2.7 Analysis of reactive oxygen species 
Cells were treated with or without 15 µM α-MSH-PEG-C’ dots for 24 hours, then 
harvested and resuspended in 500 µL Hanks Balanced Salt Solution (HBSS) (Gibco) 
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supplemented with either H2DCFDA (25 µM) or C11-BODIPY(581/591) (2 µM) 
(both from Invitrogen) and incubated for 15 minutes at 37°C. Cells were then 
resuspended in 500 µL of fresh HBSS and analyzed using the FL1 channel of a flow 
cytometer (MoFlo, Beckman Coulter). Data were collected from a minimum of 10,000 
cells per condition. 
 
2.2.8 Animal models and tumor inoculation 
All animal experiments were performed in accordance with protocols approved by the 
Institutional Animal Care and Use Committee of Memorial Sloan-Kettering Cancer 
Center and followed NIH guidelines for animal welfare. Human melanoma (M21) 
xenografts were generated on the shaved flanks of immunodeficient male SCID/Beige 
C.B-17/IcrHsd-PrkdcscidLystbg-J mice (6-8 weeks old, Harlan Laboratories, South 
Easton, MA). Human sarcoma HT1080 flank xenografts (~2.0 × 106 cells/100 ml) 
were additionally generated in the same model. Average initial tumor volumes of 55 - 
75 mm3 were used for all studies.  
 
2.2.9 In vivo dosing strategy and examination 
Five million M21 cells, cultured in serum-supplemented media, were subcutaneously 
implanted into the right flank of mice using a 23-gauge trocar needle to establish 
melanoma xenografts 2 days after particle exposure (n=3) or without exposure (n=3). 
In a subsequent study, mice were assigned to one of two different treatment groups to 
evaluate the response of HT-1080 tumors to high-concentrations (60 µM) of i.v.-
injected αMSH-PEG-C’ dots (n=5 mice; 200 µl) administered three times over a 10-
day period (i.e., days 0, 4, 7).  Control mice (n=3) were administered 0.9% saline 
vehicle at the same time points.  In a third treatment study, mice were again assigned 
to one of two groups to evaluate the response of HT-1080 tumors to three, high-
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concentration doses (60 µM) of i.v.-injected αMSH-PEG-C’ dots (n=3 mice; 200 µl) 
alone or with i.p.-administered liproxstatin-1 (n=3 mice, 10 mg/kg) over a 10-day 
period (as above). Tumor sizes were measured using calipers over the treatment 
interval. All mice were examined by palpation at the site of tumor cell inoculation, and 
were observed daily over until the termination of tumor growth studies for signs of 
morbidity or mortality. Two perpendicular diameters (d1 < d2) of the tumor used to 
calculate the tumor volume (V; 4/3·π·d12·d2/8) were measured with calipers daily 
following the injection of cells.   
 
2.2.10 In vivo fluorescence imaging 
Animals were anesthetized using isoflurane and whole body optical fluorescence 
imaging was acquired to identify nanoparticle fluorescence at the tumor site. Mice 
were scanned for 0.1 to 1 seconds using the IVIS Spectrum photon-counting device 
optical imaging system (Xenogen, Alameda, CA) with the blocks and filters for Cy5 
fluorescence (excitation 650 nm, emission 680 nm), and for background fluorescence 
(excitation 465 nm, emission 600 nm), selected according to the manufacturer’s 
recommendations. Fluorescence background was likewise subtracted according to the 
manufacturers’ instructions. Fluorescence signal was reported as radiant efficiency 
((photons/s/cm2/sr) / mW/cm2).   
 
2.2.11 Histological analysis 
Immediately after terminating the in vivo imaging study, mice were euthanized by CO2 
inhalation, and representative particle-exposed (n=2) and control (n=1) tumors were 
excised at necropsy. Excised tumors were fixed in 10% neutral buffered formalin for 
24 hours, processed in alcohol and xylene, embedded in paraffin, sectioned at 5-
micron thickness, and stained with hematoxylin and eosin (H&E). Additional sections 
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were stained by immunohistochemistry for Mac-2 (primary antibody Cedarlane 
CL8942B applied at concentration of 1:100 following heat-induced epitope retrieval 
[HIER] in a pH 6.0 buffer), myeloperoxidase (Dako A0398, 1:1000, HIER pH 6.0), 
cleaved caspase-3 (Cell Signaling Technology 9661, 1:250, HIER pH6.0), and Ki-67 
(Abcam ab16667, 1:100, HIER pH 9.0). Mac-2 staining was performed manually with 
an avidin-biotin detection system (Vectastain ABC Elite Kit, Vector Laboratories, PK-
6100). Other stains were performed on a Leica Bond RX automated stainer using the 
Bond Polymer Refine detection kit (Leica Biosystem DS9800). Sections were also 
stained by the TUNEL method as previously described. All slides were examined by a 
board-certified veterinary pathologist.  
 
2.2.12 Statistics 
Volume-time profiles were compared between the two treatment groups using robust 
standard errors calculated by a generalized estimating equations approach (Zeger et 
al., 1988). Tumor growth profiles over time for particle treatment, with and without 
inhibitor, were compared using a linear model. The longitudinal aspect of the data was 
taken into account by using generalized estimating equations.  We assigned statistical 




2.3.1 αMSH-PEG-C’ dot particles localize to the lysosome network 
To examine the effects of nanoparticle ingestion on cells, we utilized ~6 nm surface-
functionalized poly(ethylene glycol)-coated (PEGylated) near-infrared (NIR) 
fluorescent silica nanoparticles, referred to as Cornell dots (C’ dots), with diameters 
controllable down to the sub-10 nm range, reported in detail elsewhere (Ma et al., 
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2015). This FDA-IND approved hybrid organo-silica particle was previously shown to 
be a promising cancer molecular imaging agent in metastatic melanoma patients after 
functionalizing its surface with avb3 integrin-targeting peptides and radiolabels 
(Bradbury et al., 2013; Phillips et al., 2014). Preferential accumulation was observed 
within integrin-expressing primary and/or metastatic melanomatous lesions in human 
subjects and animal melanoma models (Benezra et al., 2011; Bradbury et al., 2013), 
while, at the same time, demonstrating rapid renal clearance. 
Given its potential clinical utility and its early adaptation for drug delivery 
applications (Yoo et al., 2015), we performed detailed baseline studies using the latest 
generation of C dots, referred to as C’ dots (Ma et al., 2015), that are surface-
functionalized with a 14-mer peptide analog, alpha-melanocyte stimulating hormone 
(αMSH) (Miao et al., 2007), which targets a different surface receptor expressed on 
malignant melanoma cells (i.e., melanocortin-1 receptor, MC1-R). The resulting 
αMSH-PEG-C’ dots (Fig. 2.1a) were used herein to determine the effects of dose- 
and/or time-dependent alterations in cellular survival, under particle-exposed, and also 
nutrient-deprived conditions, in  cells and tumors in vivo. Live imaging of human 
melanoma cells (M21) treated with particles for 24 hours revealed colocalization of 
fluorescent αMSH-PEG-C' dots with lysosomes, visualized by expression of a GFP-
tagged lysosomal-associated membrane protein 1 (LAMP1), indicating that ingested 
particles reside in lysosomal or late endosomal networks (Fig. 2.1b).  
 
2.3.2 αMSH-PEG-C’ dot particles induce cell death in amino acid-deprived 
conditions  
M21 cells treated with increasing concentrations of αMSH-PEG-C' dots up to 15 µM 
showed similar survival and proliferation rates to control cells (Fig. 2.2a),  
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demonstrating that incubation with even high concentrations of these nanoparticles is 
well-tolerated. We also examined the autophagy pathway and lysosome function in 
nanoparticle-treated cells, by quantifying the basal levels and turnover rates of the 
autophagy protein microtubule-associated protein 1 light chain 3 (LC3), which is 
lipidated onto autophagosomal membranes. Accumulation of the autophagosome-
associated, lipidated form of LC3 (called LC3-II) can be quantified as a measure of 
autophagy induction versus the cytosolic, non-lipidated form (called LC3-I), by 
western blotting (Fig. 2.2b). The turnover of LC3-II that occurs in a lysosome-
dependent manner can also be measured as a readout of lysosome function. When 
lysosomes are functioning properly, treatment with lysosomal inhibitors such as 
concanamycin A (ConA), which inhibits the lysosomal vacuolar-type H+-ATPase (V-
ATPase), leads to accumulation of LC3-II due to a lack of degradation; if lysosomes 
are dysfunctional, treatment with ConA will not change LC3-II levels (Mizushima et 
al., 2010). Cells treated with increasing concentrations of αMSH-PEG-C' dots for 24 
hours, from 0.15 to 15 µM, had similar relative LC3-II levels compared to control 
cells, suggesting that autophagy is not induced by nanoparticle treatment. Moreover, 
ConA treatment induced similar accumulation of LC3-II in particle-treated cells as 
compared to controls, demonstrating that lysosomes are functioning properly even 
when cells are loaded with high concentrations of αMSH-PEG-C’ dots (Fig. 2.2b). 
Although αMSH-PEG-C’ dots were well-tolerated by cells cultured under 
nutrient-replete conditions, and the autophagy pathway and lysosome function 
appeared to be unperturbed, we further examined if particle treatment might affect 
cells cultured under nutrient-deprived conditions where autophagy is induced. Cells 
cultured in amino acid-free media were treated with αMSH-PEG-C' dots and 
examined by time-lapse imaging. While amino acid deprivation was well-tolerated by  
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M21 cells in the absence of particles, the treatment of amino acid-deprived cells with 
15 µM αMSH-PEG-C' dots, which had no effect on cells in nutrient-replete media, led 
to cell death at high rates, detected by the uptake of Sytox Green, a membrane-
impermeable nucleic acid dye that labels cells with ruptured plasma membranes (Fig. 
2.2c). When injected in mice as flank tumor xenografts, which is known to cause 
nutrient deprivation (Nelson et al., 2004), M21 melanoma cells loaded with αMSH-
PEG-C’ dots demonstrated statistically significant growth-inhibition (p<0.001) over 
the study interval relative to non-particle exposed cells (Fig. 2.2d). In fact, no 
measurable growth occurred in treated tumors up to 10 days following cell injection. 
These findings suggested that αMSH-PEG-C' dots at high concentrations may induce 
cell death under conditions of nutrient deprivation in culture and in vivo. 
 
2.3.3 αMSH-PEG-C’ dot particle-induced cell death is not apoptosis, necroptosis or 
autosis 
We sought to identify the mechanism of how cells treated with αMSH-PEG-C’ dots 
undergo cell death under nutrient-deprived conditions. Careful inspection of the 
morphology of dying cells suggested a form of necrosis, involving cell swelling and 
plasma membrane rupture, in the absence of cell blebbing and fragmentation that is 
typically observed during apoptosis (Fig. 2.3a, Fig. 2.4a).  In order to more 
definitively identify the mechanism of cell death, we utilized two non-tumor cell lines, 
MCF10A human mammary epithelial cells and mouse embryo fibroblasts (MEF), that 
were also observed to die at high rates when cultured in amino acid-free media in the 
presence of αMSH-PEG-C' dots (Fig. 2.3b). Cells rendered resistant to apoptosis, by 
overexpression of the anti-apoptotic protein Bcl-2 (MCF10A-Bcl2) (Fig. 2.4b) or by 
genetic deletion of Bax and Bak (Bax/Bak-/- MEFs) (Jacobson et al., 1993;  
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Kandasamy et al., 2003) underwent cell death at similar rates compared to control 
cells, suggesting that αMSH-PEG-C' dot-induced cell death does not occur by 
apoptosis (Fig. 2.3c, d). Next, we examined if cell death was occurring by necroptosis, 
a programmed form of necrosis that requires the RIPK3 kinase (He et al., 2009). 
Ripk3-/- knockout MEFs, which are resistant to necroptosis (Fig. 2.4c), also underwent 
cell death at similar rates as controls, suggesting that nanoparticle treatment does not 
induce necroptosis (Fig. 2.3e). We further determined if a recently-described form of 
cell death involving the autophagy pathway, called autosis (Liu et al., 2013), could be 
involved, by treating autophagy-related gene 5 knockout MEFs (Atg5 -/- MEFs) that 
are completely deficient for autophagy, with α-MSH-PEG-C' dots in the absence of 
amino acids. Atg5 -/- MEFs underwent cell death at similar rates to control cells, 
demonstrating that αMSH-PEG-C' dot-induced cell death does not involve autophagy, 
and is not autosis (Fig. 2.3e). Together, these data demonstrate that cell death, induced 
by a combination of αMSH-PEG-C' dot treatment and amino acid deprivation, occurs 
independently of apoptosis, necroptosis, and autosis. 
 
2.3.4 Ferroptosis is the underlying mechanism of αMSH particle-induced cell death 
We next examined if ferroptosis, a recently described cell death mechanism that 
occurs via an iron- and reactive oxygen species (ROS)-dependent process and induced 
by glutathione depletion (Dixon et al., 2012), could be involved in αMSH-PEG-C' 
dot-induced cell death. We first tested whether ferrostatin-1, a pharmacological 
inhibitor of ferroptosis, can block cell death in this context. Indeed, ferrostatin-1 
treatment rescued cell viability, reducing cell death to the level that occurs under 
amino acid-deprived conditions in the absence of nanoparticles (Fig. 2.5a). To further 
examine if nanoparticle-induced death is dependent on iron, we treated cells with  
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deferoxamine (DFO), an iron chelator used for treating iron overload and reported to 
block ferroptosis, and observed that DFO treatment also almost completely inhibited 
cell death (Fig. 2.5b). In addition, the scavenging of ROS by treatment of cells with 
different types of antioxidants, including butylated hydroxyanisole (BHA), ascorbic 
acid (AA), or trolox, or, alternatively, by glutathione repletion through the addition of 
glutathione or N-acetylcysteine (NAC), a precursor of glutathione, could also block 
nanoparticle-induced death. Taken together, results indicated that cells cultured in the 
absence of amino acids and treated with αMSH-PEG-C’ dots undergo cell death by 
ferroptosis (Fig. 2.5c). Interestingly, ferroptosis in this context was also observed to 
propagate from cell to cell in a wave-like manner (Fig. 2.5d), unlike when cells 
undergo other types of death such as apoptosis (Fig. 2.4d), suggesting cell-cell 
communication of a death-inducing signal, and similar to a recent report of ferroptosis 
occurring in renal tubules in response to the ferroptosis-inducing agent erastin 
(Linkermann et al., 2014). 
 
2.3.5 αMSH-PEG-C’ dots induce partial tumor regression and growth inhibition in 
HT1080 xenograft models 
Having determined that MCF10A cells and MEFs undergo cell death by ferroptosis, 
we next wanted to examine if cell death could be induced in this manner by amino 
acid deprivation and nanoparticle treatment in a wider panel of cancer cells. Like 
MCF10A, MEF, and M21 cells, BxPC3 pancreatic carcinoma cells, H1650 lung 
carcinoma cells, and HT1080 fibrosarcoma cells underwent high rates of necrosis 
when treated with αMSH-PEG-C’ dots in the absence of amino acids, indicating that  
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cell death can be induced by this combination in a variety of different cancer cell types 
(Fig. 2.6a-c). 
Based on the foregoing findings, we further investigated whether particle-
induced treatment responses could be generated in HT1080 xenograft models. Using a 
multi-dosing delivery scheme, tumor growth was assessed over a 10-day period after 
three high-dose intravenous (i.v.) treatments of either the targeted particle probe (n = 
5) or 0.9% saline solution (n = 3) in immunosuppressed mice bearing flank HT1080 
fibrosarcomas. Relative to the rapidly increasing tumor volumes measured after 
injection with saline vehicle, statistically significant inhibition of tumor growth was 
observed with multiple-dose particle treatments over the study interval (Fig. 2.7a). 
Surprisingly, this was accompanied by partial tumor regression that exceeded 50% for 
all particle-treated tumors (range: 57% - 78%; mean 64%) within a 4 – 5 day interval 
after initial injection (Fig. 2.7b). In addition, by the termination of the study, 
statistically significant reductions in treated tumor volumes (mean ~85%; p<0.001) 
were found relative to control volumes (Fig. 2.7a,b). Representative whole-body 
optical imaging in mice bearing HT1080 flank xenografts demonstrated intense 
fluorescence signal at the site of tumor placement after initial αMSH-PEG-C’ dot 
injections, suggesting localization of the intravenously injected particles (Fig. 2.7c). 
H&E-stained tissue sections from representative control (n=1) and treated 
(n=2) tumors (Fig. 2.7d) revealed a poorly demarcated and invasive neoplasm, which 
was densely cellular, and composed of sheets of fusiform to polygonal cells associated 
with a fine scant stroma, and exhibiting multifocal necrosis. Control tumors were 
significantly larger on average than those of treated tumors, but no morphological 
differences were otherwise observed. Immunohistochemical staining of the control 
tumor with Mac-2, a murine macrophage marker, demonstrated small numbers of  
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Mac-2 positive macrophages in the soft tissues surrounding the tumor, while treated 
tumors were circumscribed by much larger numbers of Mac-2 positive cells in the 
same locations, as shown at both low and high magnification (Fig. 2.7e–h). 
Intratumoral Mac-2 positive cells were present in similarly small number in all tumors.  
We additionally found significantly reduced growth inhibition in HT1080 
xenografted mice (n = 3) administered three high-dose particle treatments and daily 
intraperitoneal (i.p.) doses of liproxstatin-1, a ferroptosis inhibitor recently found to 
have efficacy in vivo (Friedmann Angeli et al., 2014), over a 10-day period, relative to 
that seen with particle treatment alone (n = 3) (Fig. 2.7i). Average daily growth in 
particle-exposed tumors treated with liproxstatin-1 was 14.6 (95% CI: 10.1 – 18.9), as 
compared with -0.87 (95% CI: -1.06 to -0.69) for particle treatment alone, a difference 
of 15.3 (CI: 13.1 to 17.6; p <0.001). Corresponding particle-exposed tumor specimens 
are noted, in fact, to be significantly smaller on average than particle-treated tumors 




Here we demonstrate that the combination of treatment of cells with αMSH-PEG-C’ 
dots and starvation for amino acids that can synergize to induce the cell death program 
ferroptosis. These data suggest that targeted high-dose particle delivery to cancers and 
their ingestion within cells, under conditions that can lead to dysregulation of cellular 
redox metabolism, could render cells highly susceptible to cell death without the 
requirement for additional conjugation of cytotoxic compounds. We note that the 
combined requirement of nutrient deprivation and nanoparticle treatment for 
ferroptosis induction in this context could potentially engage tumor cells in vivo, while 
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sparing normal cells, as tumor tissues are known to undergo metabolic stress and are 
nutrient-limited compared to normal tissues. Ultrasmall targeted silica nanoparticles 
themselves have also been shown to preferentially accumulate within tumor tissues 
relative to non-tumor tissues when modified with ligands that promote targeting 
(Benezra et al., 2011; Phillips et al., 2014). 
In this study, the accumulation of nanoparticles within HT1080 xenografts 
after intravenous delivery was found to significantly inhibit tumor growth and induce 
partial tumor regression, while the further addition of liproxstatin-1 reversed these 
effects to levels nearly equivalent to those seen in tumors not exposed to particles. 
These findings underscore the potential synergy between particle treatment and 
nutrient deprivation observed in select cancer types, and suggest that, by exploiting 
such a metabolic strategy, engagement of ferroptosis could hold promising therapeutic 
potential. The significance of the marked increase in the number of macrophages 
surrounding particle-treated tumors relative to that about control lesions is not entirely 
clear, although their role in disease protection and wound repair by engulfing cellular 
debris is well-established (Ruhrberg and De Palma, 2010). It can be further 
acknowledged that macrophages are known to demonstrate a high degree of plasticity 
in response to local cues from the tumor microenvironment (Biswas and Mantovani, 
2010; Van Overmeire et al., 2014), and can assume a spectrum of roles upon 
activation that are required for maintaining tissue homeostasis (Mosser and Edwards, 
2008), including shifts in their function associated with tumor shrinkage (Guiducci et 
al., 2005). 
While the concentration of nanoparticles used here to either induce in vitro cell 
death or promote in vivo growth inhibition and regression is at least four orders of 
magnitude higher than what is used currently in human subjects for single-dose 
imaging-based studies (Phillips et al., 2014), local concentrations could be driven to 
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much higher levels at tumor sites as part of a multi-dosing strategy, combinatorial 
treatment regimen, and/or by direct catheter infusion at the target site. Such a dosing 
schedule would be designed to yield maximum tumor-to-background ratios while 
reducing off-target toxicities and promoting efficient renal clearance. It is notable that 
the leakiness of tumor vasculature is thought to allow the accumulation of 
systemically injected nanoparticles in tumor tissues (Gabizon et al., 2014), while 
contributing to nutrient deprivation within tumors, again suggesting that the synergism 
between nanoparticles and nutrient deprivation may be restricted to tumor sites in vivo.  
We also note that different tumor cell lines apparently differ in their sensitivity 
to this ferroptosis-inducing mechanism, as we have found, for example, that HT1080 
fibrosarcoma cells underwent αMSH-PEG-C' dot-induced ferroptosis even under 
nutrient-replete conditions (Fig. 2.6c), and in amino acid-deprived conditions with 10-
fold lower nanoparticle concentration (1.5 µM) (Fig. 2.8). Targeted particle uptake 
into HT1080 cells, in this instance, presumably occurred via a non-specific endocytic 
route, as previous studies identified this route as one of two possible cellular 
internalization pathways utilized by these probes (Benezra et al., 2014). As ferroptosis 
is an iron-dependent cell death, it is conceivable that differential susceptibilities may 
relate in part to the amount of iron that is available in cells. Iron is not only an 
essential component for cellular homeostasis, but can also generate ROS that can 
damage organelles. Cells regulate iron availability by uptake, export, or a shift from 
storage to the labile iron pool (LIP) and some of these processes are altered in cancer 
(Richardson et al., 2009). The oncogenes c-myc and E1a reduce levels of ferritin, the 
main cytosolic iron storage protein, which can shift iron from storage to the 
metabolically active LIP (Tsuji et al., 1993; Wu et al., 1999) and repression of ferritin 
can stimulate Ras-dependent proliferation most likely by activating DNA synthesis 
(Kakhlon et al., 2002). Interestingly, ferroptosis-inducing drugs were initially  
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discovered in a screen of small molecules that confer selective killing of Ras-driven 
tumor cells (Yang and Stockwell, 2008), and among the tested cancer cell lines above, 
HT1080 is the only cell line harboring a Ras mutation. Therefore, it may be interesting 
to examine whether cancer cells with mutant Ras are generally more sensitive to 
nanoparticle treatment. 
Some nanomaterials, including uncoated silica particles with diameters on the 
order of 63 nm (i.e., order of magnitude larger than C' dots) have been shown to 
induce ROS in cells (Yu et al., 2014). By contrast, we have not detected increased 
levels of either cytosolic or lipid ROS in cells treated for 24 hours with sub 10-nm 
diameter α-MSH-PEG-C’ dots (Fig. 2.9b), which have an essentially neutral charge. 
We have found that amino acid starvation and nanoparticle treatment both lower 
glutathione levels in cells, and also have an additive effect (Fig. 2.9c), suggesting that 
cell death in this context may be triggered, at least in part, by glutathione depletion 
(Fig. 2.9d), similar to the ferroptosis-inducing agent erastin that inhibits glutathione 
production by limiting cystine uptake. The nanoparticles used here are surface-
modified with αMSH peptides for targeting cancers in vivo, and this modification also 
enhances cellular uptake (data not shown). In this context, particle modification does 
not appear to be involved in ferroptosis, as we have observed ferroptosis induction 
even with PEG-coated C’ dots that are unmodified with αMSH targeting ligands, 
although death in this context occurs with slower kinetics, likely due to slower uptake 
of the base particles than of αMSH-modified platforms in MC1-R-expressing 
melanoma cells (Fig. 2.9a). On the other hand, particle size was found to play a critical 
role in the induction of ferroptotic effects under amino acid deprived conditions. 
Relative to the high percentage of Sytox Green labeled HT1080 cells (i.e., 80%) found 
48 hours after exposure to smaller diameter (~6 nm) PEGylated C’ dots, the  
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percentage of labeled cells found after incubation with larger diameter (~10 nm) 
particles was much lower, on the order of 25%, only slightly increased over non-
treated cells (Fig. 2.10).  
It will be important in future studies to identify mechanisms whereby C’ dots 
contribute to ferroptosis, and whether other controlled variations in particle structure, 
composition, or surface chemical properties may alter, or even abrogate, induction of 
ferroptotic effects. The discovery of nanoparticle-induced ferroptosis as a redox 
modulator of cell fate, as well as a mediator of tumor regression and growth inhibition, 
suggests that it may be possible to exploit this process therapeutically to 
synchronously and selectively kill cancers sensitive to an iron-dependent, non-
apoptotic cell death program.  
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As discussed in chapter one, in addition to apoptosis, or type I cell death, which is well 
known to control cell turnover during metazoan development and in adult tissues, 
other alternative, non-apoptotic forms of programmed cell death have been identified 
recently, and these also contribute to physiologic cell turnover in some contexts 
(Galluzzi et al., 2012; Tait et al., 2014; Yuan and Kroemer, 2010). For example, forms 
of programmed necrosis, or type III cell death, eliminate cells during viral infection or 
ischemia-reperfusion (Linkermann and Green, 2014), and autophagic, or type II, cell 
death participates in development (Das et al., 2012) and may eliminate stressed cells in 
adult tissues (Liu et al., 2013). In addition to these programs, it is also evident that 
cells can be targeted for death by being engulfed by professional phagocytes or by 
neighboring cells (Brown and Neher, 2012; Overholtzer and Brugge, 2008). Examples 
of cell death-inducing engulfment mechanisms include entosis (Overholtzer et al., 
2007), emperitosis (Wang et al., 2013), suicidal emperipolesis (Benseler et al., 2011), 
phagoptosis (Brown and Neher, 2012), and homotypic cell cannibalism (HoCC) (Cano 
et al., 2012). While cell engulfment appears to be the cause of cell death for these 
programs, little is known about the molecular mechanisms that regulate the death of 
ingested cells in these contexts. In fact, engulfment appears to be insufficient to cause 
cell death in some circumstances, as entotic cells and those engulfed by HoCC have 
been shown to escape, post-engulfment, and thereby avoid execution (Cano et al., 
2012; Overholtzer et al., 2007). 
We have previously found that engulfed entotic cells do not have access to 
growth factors, have low levels of mTOR activity compared to neighboring cells, and 
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upregulate autophagy, suggesting that they are shielded from the extracellular medium 
and are nutrient-deprived. However, many of these live engulfed cells can survive for 
prolonged periods, from hours to days, within entotic vacuoles of host cells and can 
even undergo division in some cases (Overholtzer et al., 2007). Their prolonged 
survival appears to depend at least in part on the induction of autophagy, as autophagy 
inhibition by siRNA-mediated knockdowns within engulfed cells leads to a high rate 
of apoptosis (Florey et al., 2011). Intriguingly, autophagy proteins also function to 
execute the non-apoptotic death of ingested cells, by acting within engulfing cells to 
lipidate the autophagy protein microtubule-associated protein light chain 3 (LC3) onto 
entotic vacuoles (Florey et al., 2011). LC3 lipidation is followed by the fusion of 
lysosomes, whose enzymes appear to kill and digest engulfed cells. A similar activity 
of autophagy pathway proteins occurs during phagocytosis and macropinocytosis and 
is thought to control vacuole maturation, perhaps by facilitating lysosome fusion 
(Florey and Overholtzer, 2012).  
But while phagosome maturation involving LC3 lipidation occurs rapidly after 
engulfment, entotic vacuoles exhibit a maturation delay of hours or even days, 
suggesting that engulfment per se is insufficient to trigger LC3 lipidation and the 
death of internalized cells, and that there may be additional signals (Florey et al., 
2011). Why entotic vacuoles exhibit delayed maturation, and the nature of the signal 
that ultimately triggers maturation, are unknown. Like cells ingested by entosis, the 
predominant fate of cells ingested by suicidal emperipolesis or phagoptosis is 
considered to be cell death (Benseler et al., 2011), but detailed imaging-based 
quantification of the fates of engulfed cells, including the kinetics of death and 
whether targeted cells can be rescued post-engulfment, have not been performed.  
To investigate the regulation live cell engulfment-induced cell death, we 
sought to identify pathways that might control cell death initiation, or contribute to the 
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prolonged survival of engulfed cells, potentially by inhibiting cell death. Surprisingly, 
even though engulfed cells appear to be shielded from the outside environment, we 
found that the withdrawal of amino acids from culture medium induced live engulfed 
cells to undergo apoptosis. Similarly, inhibition of the mTOR kinase, which is 
regulated by amino acids, induced apoptosis of engulfed cells, dependent on the 
expression within engulfed cells of 4E-BP1, a known negative regulator of mRNA 
translation and an mTORC1 effector protein. Similar to entosis, we find that the fate 
of cells ingested by HoCC, but not phagoptosis, is also controlled by mTOR signaling 
and amino acids from media, suggesting that live engulfed cells may acquire nutrients 
from the external environment that prolong cell survival. Interestingly, mTOR 
inhibition also affected the rate of non-apoptotic cell death by acting within engulfing 
cells, in a manner not requiring 4E-BP1. Together these data identify amino acid 
signaling and mTOR activity as key determinants controlling the fate of live engulfed 
cells, and further suggest that engulfed cells may feed through an unknown 
mechanism that prolongs their survival.  
 
3.2 MATERIALS AND METHODS 
 
3.2.1 Cell culture and constructs 
MCF10A cells (ATCC) were cultured in DMEM/F12 (Gibco, Grand Island, NY) 
supplemented with 5% horse serum (Atlanta Biologicals, Flowery Branch, GA), 20 
ng/ml EGF (Peprotech, Rocky Hill, NJ), 10 µg/ml insulin (Sigma, St. Louis, MO), 0.5 
µg/ml hydrocortisone (Sigma), and 100 ng/ml cholera toxin (Sigma) with 
penicillin/streptomycin. BxPC3 cells (ATCC) were cultured in RPMI-1640 (Gibco) 
supplemented with 10% FBS with penicillin/streptomycin. RAW 264.7 and Jurkat 
cells (ATCC) were cultured in DMEM (Gibco) supplemented with 10% FBS with 
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penicillin/streptomycin. Cells were routinely verified as mycoplasma-free by DAPI 
imaging. Amino acid-free medium was prepared by dialyzing heat-inactivated FBS 
(for BxPC3, RAW 264.7, and Jurkat cells) or horse serum (for MCF10A cells) for 4 h, 
followed by overnight incubation at 4°C in phosphate-buffered saline (PBS) in 
MWCO 3500 dialysis tubing (21-152-9; Fisherbrand, Pittsburgh, PA) and addition to 
base media prepared without amino acids. GFP-LC3, H2B-mCherry, and H2B-GFP 
were introduced into MCF10A, BxPC3, or RAW 264.7 cells by retroviral 




The following reagents were used at the indicated concentrations: Torin1 (Tocris, 
Ellisville, MO) 0.5 µM, 5-Bromo-2-Deoxyuridine (BrdU) (Sigma) 10 µM; 
Concanamycin A (ConA) (Sigma) 100 nM; anti-CD47 antibody (ab3283; Abcam, 
Cambridge, MA) 10 µg/ml. 
 
3.2.3 Immunofluorescence 
The following antibodies were used for immunofluorescence (IF): Anti-phospho-
mTOR (5536; Cell Signaling, Danvers, MA), Anti-LAMP1 (555798; BD Biosciences, 
San Jose, CA), Anti-BrdU (5292; Cell Signaling). IF was performed on cells cultured 
on glass-bottom dishes (Mattek), essentially as described (Overholtzer et al., 2007). 
Confocal microscopy was performed with the Ultraview Vox spinning-disc confocal 
system (Perkin Elmer) equipped with a Yokogawa CSU-X1 spinning-disc head and an 
EMCCD camera (Hamamatsu C9100-13), and coupled to a Nikon Ti-E microscope. 
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3.2.4 Western blotting 
Cells were scraped into ice-cold RIPA buffer (50 mM Tris at pH 7.4, 150 mM NaCl, 2 
mM EDTA, 1% NP40, 0.1% SDS with protease inhibitor cocktail) and lysed for 10 
min on ice. Lysates were then centrifuged at 15,870g for 20 min at 4 °C and protein 
was quantified by BCA assay (Pierce, Waltham, MA). Samples were separated on 
15% polyacrylamide SDS–PAGE gels and transferred to a polyvinyldifluoride 
membrane which was blocked with TBST plus 5% BSA and incubated overnight at 4 
°C with the following primary antibodies: Anti-mTOR (2983; Cell Signaling), Anti-
4E-BP1 (Cell Signaling), Anti-LC3A/B (4108; Cell Signaling) and anti-Actin (A1978; 
Sigma), diluted in blocking buffer. Blots were incubated with horseradish peroxidase 
conjugated to secondary antibodies and protein was detected using enhanced 
chemiluminescence detection (Invitrogen, Carlsbad, CA). Densitometry analysis was 
carried out using ImageJ software (NIH). 
 
3.2.5 siRNA and shRNA mediated protein knockdown 
siGenome SMART pool siRNA against human mTOR, FIP200 as well as Control 2 
non-targeting siRNAs, were obtained from Dharmacon. MCF10A cells were seeded in 
a 6-well plate at 5 x 104 per well and transfected with 100 nM siRNA using 
Oligofectamine (Invitrogen). Cells were assayed 48 hours post-transfection. shRNA 
constructs targeting human Atg13 in the pLKO.1 vector, as well as empty vector, were 
acquired from the MSKCC core facility. Cells were selected with puromycin and 
assayed 72 hours after selection. 
 
3.2.6.CRISPR/Cas9 gene knockout system 
Vectors encoding guide RNA (sequence) targeting exon of 4E-BP1 were cloned as 
previously described (Mali et al., 2013). MCF10A cells were co-transfected with 
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gRNA vector and the Cas9 vector. After 3 days, cells were seeded as single colonies in 
96-well plates and left to grow for 2-3 weeks. Clones were selected based on western 
blotting. 
 
3.2.7 Time-lapse microscopy 
Cells were plated onto glass-bottom 6-well plates (MatTek, Ashland, MA) overnight 
and fluorescence and differential interference contrast (DIC) images were acquired 
every 10 min for indicated times using a Nikon TI-E inverted microscope, a 
CoolSNAP HQ2 CCD (charge-coupled device) camera (Photometrics, Tucson, AZ), a 
live-cell incubation chamber to maintain cells at 37 °C and 5% CO2, and NIS 
Elements software (Nikon, Melville, NY). Cell fates, including cell survival, death, 
and proliferation, were manually quantified and processed using NIS Elements 
software and Image J. 	  
3.2.8 BrdU incorporation assay 
MCF10A cells were plated in glass-bottom 6-well plates and treated with DMSO or 
Torin1 with the addition of BrdU. After 24 hours, cells were fixed and immunostained 
with an anti-BrdU antibody. 
 
3.2.9. Phagoptosis assay 
RAW 264.7 cells were plated in glass-bottom 6-well plates in full media with 200 
U/ml IFN-γ. After 48 hours, RAW 264.7 cells were overlayed with 2.5x105 
trypsinized MCF10A cells expressing H2B-mCherry and imaged for 15 hours. Cell 
fates, including engulfment and death, were manually quantified and processed using 
NIS Elements software and Image J. 
 
	   64	  
3.3 RESULTS 
 
3.3.1 Amino acid starvation or mTOR inhibition induces apoptosis of live engulfed 
entotic cells. 
Entosis leads to the formation of cell-in-cell structures that harbor viable epithelial 
cells that have been engulfed by their neighbors. These engulfed cells do not appear to 
have access to culture media, as they have been shown to lack access to a fluorescent-
tagged epidermal growth factor (EGF), and they also upregulate autophagy, a known 
starvation response that is required for entotic cell survival (Florey et al., 2011). 
Consistent with a lack of access to nutrients, we found that internalized entotic cells 
also display low levels of mTOR activity compared to host and neighboring cells, as 
determined by immunostaining for mTOR phosphorylated on serine 2448, that 
indicates activated mTOR kinase (Fig. 3.1a). As shown previously, when cell-in-cell 
structures cultured in nutrient-replete conditions were observed by time-lapse 
microscopy for 20 hours, the majority of cell deaths that were observed were non-
apoptotic in nature, as determined by nuclear morphology, while only about 5-10% of 
engulfed cells underwent apoptotic cell death, indicated by nuclear condensation and 
fragmentation, as well as membrane blebbing (Fig. 3.1b). We also found that the 
autophagy protein LC3, which is lipidated onto entotic vacuoles prior to non-apoptotic 
cell death, was not lipidated prior to apoptotic cell death, as reported (Fig. 3.1b). 
Surprisingly, although internalized cells are shielded from the extracellular 
environment, have low levels of mTOR activity, and upregulate autophagy, we found 
that the removal of amino acids from culture medium induced cell death by apoptosis 
(Fig. 3.1c). Furthermore, although internalized cells exhibit low levels of 
immunostaining for active mTOR, the inhibition of mTOR kinase activity, by 
treatment with the inhibitor Torin1, similarly resulted in apoptosis (Fig. 3.1d). These  
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data demonstrate that the fate of live engulfed cells during entosis is regulated, 
surprisingly, by the availability of extracellular amino acids and activity of the amino 
acid-responsive mTOR kinase.  
 
3.3.2 Amino acid starvation or mTOR inhibition induces apoptosis of live engulfed 
cells during HoCC. 
To examine if the fates of live engulfed cells formed by other engulfment process are 
also regulated by amino acid signaling, we examined cell-in-cell structures formed by 
pancreatic carcinoma BxPC3 cells, which have been shown to be formed by a process 
called homotypic cell cannibalism (HoCC), argued to be distinct from entosis (Cano et 
al., 2012). Similar to entotic cell structures, some engulfed cells resulting from HoCC 
underwent cell death with an apoptotic morphology, with membrane blebbing and 
nuclear condensation, and an absence of LC3 lipidation (Fig. 3.2a). When cells were 
starved for amino acids or treated with Torin1, the rates of apoptosis increased 
significantly, similarly to the fates of entotic cells (Fig. 3.2b). This demonstrates that 
the fates of engulfed cells within HoCC-mediated cell-in-cell structures are also 
regulated by amino acids and mTOR activity in a similar manner to entotic cells.  
 
3.3.3 mTOR activity is required within engulfed cells for survival. 
To further examine how mTOR controls the survival of engulfed cells, we sought to 
determine which cells, the host or internalized cells, might require amino acid 
signaling and mTOR activity. We examined the requirement of mTOR for cell 
survival in different cell populations by mixing control cells expressing a green 
fluorescent marker of the nucleus (H2B-GFP) with those expressing a red fluorescent 
marker of the nucleus (H2B-mCherry), and then treated red cells with mTOR-targeted  
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siRNA (Fig. 3.3a). Cell-in-cell structures in mixed cultures were examined by time-
lapse microscopy and the frequencies of apoptotic cell death were quantified over 
time. Among the possible combinations of host and engulfed cell relationships, we 
found that when mTOR was depleted from engulfed cells, not host cells (Fig. 3.3b), 
the frequency of apoptosis was significantly increased (Fig. 3.3c), consistent with a 
requirement for amino acid signaling and mTOR activity to maintain the viability of 
engulfed cells in an autonomous manner. 
 
3.3.4 4E-BP1 is required for apoptosis occurring in response to mTOR inhibition.  
As the amino acid-responsive mTORC1 kinase complex is known to phosphorylate 
translational machinery to regulate protein synthesis, we examined the potential 
involvement of the known mTOR effector 4E-binding protein 1 (4E-BP1) (Dowling et 
al., 2010). 4E-BP1 interferes with the interaction between eukaryotic translation 
initiation factor 4E (eIF4E) and eIF4G, leading to a block of translation initiation, but 
when phosphorylated by mTOR, 4E-BP1 dissociates from eIF4E and allows protein 
synthesis to begin (Ma and Blenis, 2009). Therefore, in cells depleted for 4E-BP1, 
translation initiation, as well as cell proliferation, are rescued in the context of mTOR 
inhibition (Dowling et al., 2010). We generated cells depleted of 4E-BP1 (Fig. 3.4a), 
using the CRISPR/Cas9 system, and observed that the proliferation arrest that is 
normally caused by mTOR inhibition was partially relieved, consistent with a previous 
report (Fig. 3.4b). We next examined the frequencies of apoptosis of these cells in 
mTOR-inhibited conditions, and observed that 4E-BP1-depleted cells were rescued 
from apoptotic death caused by the inhibition of mTOR (Fig. 3.4c). Furthermore, 
consistent with the requirement of mTOR signaling within in engulfed cells to 
promote cell survival, we found that the knockout of 4E-BP1 within engulfed cells  
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could rescue, in a cell-autonomous manner, apoptosis induced by mTOR inhibition 
(Fig. 3.4d). 
 
3.3.5 Non-apoptotic death of engulfed cells in entosis is also regulated by amino 
acids and mTOR. 
Live engulfed cells in entosis can undergo another type of cell death that is 
morphologically and genetically distinct from apoptosis, but rather requires autophagy 
proteins from the host cell and is dependent on the lysosomal fusion to vacuoles that 
harbour engulfed cells (Fig. 3.5a) (Florey et al., 2011). We observed the frequencies of 
this cell death and noticed that amino acid starvation and mTOR inhibition led to a 
decrease in rates of non-apoptotic death (Fig. 3.5b). It has been shown previously that 
the autophagy proteins, which are required for lysosomal fusion and subsequent death 
of engulfed cells, are specifically required within the host cells (Florey et al., 2011). 
To examine which cell requires mTOR activity for regulation of non-apoptotic cell 
death, we performed mixing experiments with red and green cells and examined the 
non-apoptotic cell death rates of engulfed cells within mixed cell-in-cell structures. 
Unlike apoptotic cell death, the siRNA-mediated knockdown of mTOR within host 
cells, but not internalized cells, reduced the rate of non-apoptotic cell death (Fig. 3.5c). 
However, when we depleted the mTOR effector protein 4E-BP1 from host cells, the 
rates of non-apoptotic cell death were unchanged, suggesting that mTOR does not 
regulate non-apoptotic death through 4E-BP1 (Fig. 3.5d). 
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3.3.6 mTOR does not act through autophagy to regulate non-apoptotic death during 
entosis. 
As amino acid starvation and mTOR inhibition are known to upregulate autophagy, 
and autophagy proteins contribute to regulating entotic cell death (Florey et al., 2011), 
we sought to determine whether it was the upregulation of autophagy by these 
treatments that was inhibiting non-apoptotic death frequencies, perhaps by inducing 
competition between these processes for shared autophagy proteins such as LC3. To 
examine this, we took advantage of the fact that non-apoptotic cell death is regulated 
independently of the ULK1/2/FIP200/ATG13 complex that is required for autophagy 
(Florey et al., 2011). As shown in Figure 3.6a-b, the siRNA-mediated knockdown of 
FIP200, or shRNA-mediated knockdown of ATG13, reduced the amount of lipidated 
LC3 (LC3-II) induced by treatment with Torin1, consistent with the inhibition of 
autophagy. However, these autophagy-inhibited cells still exhibited reduced non-
apoptotic cell death frequencies upon treatment with Torin1 (Figure 3.6c-d), 
suggesting that mTOR inhibition does not regulate non-apoptotic cell death 
frequencies by inducing autophagy and sequestering autophagy proteins.  
 
3.3.7 The fates of live engulfed cells within HoCC cell-in-cell structures, but not 
CD47-blockade-induced phagocytosis, are regulated by amino acids and mTOR. 
To ask whether other live engulfment programs undergo similar non-apoptotic cell 
deaths that are also regulated by amino acids and mTOR, we decided to look at HoCC 
and phagoptosis, a process of live engulfment induced by the blockage of CD47, a 
“don’t-eat-me” signal in cells (Brown and Neher, 2012). First, we found that live 
engulfed cells within HoCC cell-in-cell structures can also undergo non-apoptotic cell 
death associated with LC3 lipidation onto vacuoles (Fig. 3.7a), and we found that the  
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frequencies of these deaths were also decreased with amino acid starvation or mTOR 
inhibition, similar to entosis (Fig. 3.7b). Anti-CD47 antibody-mediated phagocytosis, 
also termed phagoptosis, is a type of live cell engulfment that is induced by the 
blockade of CD47, a molecule which functions as a “don’t-eat-me” signal, on viable 
cells (Chao et al., 2012). Normally, live lymphocytes are not engulfed by macrophages 
when incubated together even for a prolonged time (Fig. 3.8aA-A’’’). However, when 
they are incubated in the presence of an anti-CD47 antibody that targets CD47 on the 
lymphocytes, this induces phagocytosis of the lymphocytes by the macrophages (Fig. 
3.8aB-B’’’), as previously reported (Chao et al., 2012). We found that phagosomes 
containing live lymphocytes follow a similar maturation process to entotic vacuoles, 
consisting of LC3 lipidation and lysosome fusion, occurring prior to internalized cell 
death (Fig. 3.8b). The death of the lymphocytes was dependent on lysosome function, 
as pre-treatment with the lysosome inhibitor concanamycin A, which blocks the 
vacuolar type ATP-dependent H+ pump (V-ATPase), inhibited cell death, and 
engulfed cells under this condition appeared to survive and move continuously within 
phagosomes for prolonged periods, up to more than 5 hours (Fig. 3.8aC-C’’’). To ask 
whether mTOR can regulate this non-apoptotic cell death caused by phagoptosis, we 
treated macrophages with Torin1 and added cells targeted with CD47 antibodies. 
Unlike entotic or HoCC-related non-apoptotic cell deaths, treatment with Torin1 did 
not alter the frequencies of cell death by phagoptosis (Fig. 3.8c), suggesting that the 
observed regulation of cell death by amino acids or mTOR during entosis and HoCC 
does not occur during phagoptosis. This may be related to the observation that 
engulfment and death of the engulfed cell is tightly correlated during phagoptosis, as 
phagosomes mature rapidly after engulfment, and engulfed cells die quickly, 
becoming acidified and ceasing movement within approximately 30 minutes to one  
	   76	  
 
	   77	   
	   78	  
hour after ingestion (Fig. 3.8a). Even when cells were targeted for either phagoptosis 
or entosis in the same culture conditions, engulfed cells formed by phagoptosis died 
rapidly after engulfment, unlike those formed by entosis or HoCC, in which death of 





Here we identify the amino acid-mTOR-4E-BP1 pathway as a regulator of apoptosis 
of live engulfed cells formed by entosis or HoCC. Amino acid withdrawal or mTOR 
inhibition increases the frequencies of apoptosis compared to when cells are cultured 
in nutrient-replete conditions. This increase of apoptosis by mTOR inhibition is 
completely rescued by depletion of the 4E-BP1 protein, suggesting that amino acid-
mTOR signaling exerts control over this process by regulating mRNA translation. The 
activity of the mTOR-4E-BP1 pathway is specifically required within engulfed cells to 
prevent their death through apoptosis. This is a somewhat surprising result as we have 
previously shown that live engulfed cells formed by entosis already have decreased 
mTOR activity, even in nutrient-replete conditions. This suggests that some engulfed 
cells may retain a certain threshold of mTOR activity, although lowered compared to 
control cells, perhaps through amino acid signaling from the medium. When the 
culture medium is devoid of amino acids or when mTOR activity is blocked by 
inhibitor treatment, engulfed cells then succumb to apoptosis. It is possible therefore 
that engulfed cells acquire small amounts of amino acids that function to sustain a low, 
yet sufficient level of mTOR activity that promotes cell survival. While the methods 
of mTOR inhibition shown here (Torin 1 treatment or siRNA-mediated knockdown) 
both block mTORC1 and mTORC2 activity, the finding that the known mTORC1 
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effector 4E-BP1 plays a role in cell death, specifically implicate the mTORC1 
complex as a regulator of entotic cell death in this context. 
How engulfed cells can acquire nutrients from medium is unknown and an 
important question to be addressed by further studies. It is possible that engulfed cells 
could acquire amino acids from the cytosol of host cells, as these can be shared 
directly through gap junctions. We have evidence that the entotic vacuole membrane, 
within which live engulfed cells are contained, retains characteristics of the plasma 
membrane for prolonged periods, including localization of E-cadherin and transferrin 
receptor (data not shown). It may be possible that gap junction complexes could also 
be present and could mediate the transfer of amino acids to internalized cells. 
Alternatively, it may possible that endocytic vesicles, such as macropinosomes, could 
be ingested by host cells and recycled to the membrane surrounding engulfed cells, 
which could also deliver nutrients.  
Live engulfed cells ingested by entosis or HoCC can also undergo another, 
more frequent type of death that requires the autophagy proteins within host cells, and 
we also find that mTOR is a regulator of this process. The mTOR effector(s) that may 
participate as regulators of non-apoptotic cell death in this context are unknown. We 
have previously shown that autophagy pathway proteins participate in entotic cell 
death by facilitating vacuole maturation, and that depletion of the autophagy 
machinery that controls LC3 lipidation also reduces non-apoptotic cell death 
frequencies in entosis (Florey et al., 2011). But here we find that the regulation of non-
apoptotic cell death by mTOR appears unrelated to its control over autophagy, 
consistent with previous findings that autophagy induction is unrelated to phagosome 
maturation (Sanjuan et al., 2007).  
Here we also found that the death of tumor cells ingested by HoCC is, like 
entotic cell death, regulated by the availability of extracellular amino acids and mTOR 
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activity, while the death of live cells ingested by phagoptosis is not; although both 
types of engulfments engage in LC3 lipidation and lysosome fusion. As entosis and 
HoCC are associated with an apparent vacuole maturation delay compared to 
phagoptosis (Fig. 3.8d), we speculate that the initiation of vacuole maturation in the 
context of epithelial cell-cell engulfment requires a secondary, post-engulfment signal, 
regulated by mTOR, that is not directly related to the engulfment itself, and perhaps 
macrophage-driven phagoptosis bypasses this requirement. Indeed, we show here that 
ingestion of the same target epithelial cell (MCF10A) is associated with a maturation 
delay only when neighboring epithelial cells, and not macrophages, mediate the 
engulfment. The engagement of Fcγ-receptors on macrophages by the anti-CD47 
antibody used to trigger phagoptosis could conceivably play a role to facilitate rapid 
phagosome maturation in this context. The identity of the protein or proteins required 
for vacuole maturation during entosis or HoCC that are synthesized in an mTOR-
dependent manner is an important topic for future studies.  
Our findings highlight an important concept for the study of live cell 
engulfment programs; that internalized cells can undergo cell death, which occurs 
post-engulfment, by distinct mechanisms. Our findings here demonstrate that, to our 
surprise, the withdrawal of amino acids from culture medium induces apoptosis of 
internalized cells, while inhibiting entotic cell death. This makes an important 
prediction that cells engulfed by entosis or HoCC within tumors may also undergo cell 
death, post-engulfment, by apoptosis, especially when amino acids are limiting in the 
environment. Therefore, the identification of apoptotic engulfed cells within tumor 
sections does not necessarily indicate the mechanism by which those cells were 
engulfed, as entosis, which typically leads to non-apoptotic cell death in nutrient-
replete conditions, is associated with apoptosis during starvation. Finally, while 
nutrient restriction is shown here to change the mechanism of cell death for engulfed 
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cells, it does not alter the frequency of death, unless cells overexpress a strong 
inhibitor of apoptosis like Bcl2. Therefore, we find that cells can still cause the death 
of their neighbors, by entosis or HoCC-mediated ingestion, in the absence of 
exogenous amino acids, suggesting that the inhibition of transformed growth by 
entosis (Florey et al., 2011; Overholtzer et al., 2007), as well as nutrient recovery from 
ingested entotic cells (Krajcovic et al., 2013), may occur similarly under conditions of 
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The mechanisms of recently discovered non-apoptotic cell death forms and the 
metabolic regulation of these cell death processes are poorly understood. In my thesis 
research, we have found that amino acid starvation can lead to ferroptosis of cells that 
have been treated with ultrasmall particles through depletion of cellular glutathione 
levels. This suggests that these ultrasmall silica nanoparticles, under nutrient-deprived 
conditions, can be utilized as inducers of ferroptosis. Starvation of amino acids, in this 
scenario, leads to a decrease in intracellular glutathione levels, most likely caused by a 
deprivation of cystine, and causes cells to become more susceptible to oxidative stress. 
We have found that in vivo xenograft growth, which is accompanied by nutrient 
deprivation, was also inhibited with intravenous injections of these nanoparticles. As 
these ultrasmall silica particles have been approved by FDA-IND to be used as a 
cancer molecular imaging agent, this opens the possibility of the utilization of these 
particles as therapeutic agents to induce ferroptosis. An interesting observation we 
have made of nanoparticle-induced ferroptosis is that the death of cells in a clonal 
population can be propagated to neighboring cells in a wave-like manner. This is a 
novel mechanism of cell death that is not observed in other forms of death such as 
apoptosis and necroptosis. This spread of death may be dependent on cell-to-cell 
contact in which a death-inducing molecule, or molecules, propagates to neighboring 
cells. 
 We have also found that the death of live engulfed cells can be regulated by 
amino acids and mTOR activity. We find that amino acid withdrawal or mTOR 
inhibition induces apoptosis of engulfed cells and also disrupts entotic cell death that 
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is associated with the lipidation of LC3 to entotic vacuoles. The knockdown of mTOR 
in engulfed cells induces apoptosis of these cells, suggesting that mTOR is needed for 
survival of these cells. Conversely, the knockdown of mTOR specifically within host 
cells inhibits entotic cell death, suggesting that mTOR plays a role in vacuole 
maturation in this context. We find that cells ingested by two other live cell 
engulfment programs, homotypic cell cannibalism (HoCC) and anti-CD47 antibody-
mediated phagocytosis, also known as phagoptosis, also undergo a similar vacuole 
maturation sequence involving LC3 lipidation and lysosome fusion, but only HoCC 
involves mTOR-dependent regulation of vacuole maturation and cell death, similar to 
entosis. We further find that the regulation of apoptosis by mTOR involves the 4E-
BP1 protein that is a known regulator of mRNA translation. The knockout of 4E-BP1 
in engulfed cells rescues these cells from undergoing apoptosis caused by mTOR 
inhibition. These data identify amino acid signaling and the mTOR-4EBP-1 pathway 
as a survival pathway for live engulfed cells formed by entosis and HoCC. 
 
4.2. FUTURE DIRECTIONS 
 
4.2.1 Molecular mechanism of ferroptosis 
We have identified a novel mechanism of inducing ferroptosis of cells by the 
combination of amino acid starvation and nanoparticle treatment. Ferroptosis itself is a 
newly described form of cell death and not many molecular players have been 
identified for the signaling pathways related to the death process, at least by 
comparison to another mechanism of programmed necrosis, necroptosis. For 
necroptosis, it is becoming clear that necrosis is a highly regulated process involving 
kinase-mediated control over a protein complex that may function as a pore to 
promote cell rupture. These layers of molecular control are not yet apparent for 
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ferroptosis, but if more machinery exists for this mechanism it will be important to 
identify. The potent ability of ferroptosis to eliminate entire cell populations should 
facilitate screening efforts to identify, by loss-of-function approaches, genes whose 
products are required for cell death in this context, as resistant cells may be able to 
grow out over a clean background in cellular assays. In the case of necroptosis, the 
discovery of the RIP1 kinase and its inhibitor, necrostatin-1, accelerated the field not 
only by elucidating molecular mechanism, but also by identifying a kinase inhibitor 
that could be used as a test to examine if particular death processes occur by this 
program. If kinases also control ferroptosis, their identification could similarly 
accelerate the field. Using CRISPR-Cas9 technology, it should be possible to conduct 
a pooled kinase knockout screen to enrich for resistant cells in ferroptosis-inducing 
conditions, in order to discover potential kinases that may be essential to this death 
process.  
We have found that ultrasmall nanoparticle treatment can inhibit the growth of 
melanoma and fibrosarcoma xenograft tumors in vivo by inducing ferroptosis, It will 
be important in future work to expand these studies to investigate if other types of 
tumors are also susceptible to this treatment. Renal cancer cells have been shown to be 
more sensitive to ferroptosis than other cell types (Yang et al., 2014), and by analyzing 
the susceptibility for ferroptosis in a panel of patient-derived renal cancer cell lines 
(Hakimi et al., 2016), it may be possible to identify certain pathways or mutations that 
confer ferroptotic sensitivity to cells. For example, a recent study has shown that 
glutaminolysis is required for ferroptosis (Gao et al., 2015) and there may be other 
pathways whose activity confers sensitivity to this form of cell death. The 
identification of mutations or expression patterns that confer sensitivity will be 
invaluable for future studies to identify cancers that could potentially be treated by 
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strategies aimed at inducing ferroptosis, or to identify potential efficacious 
combination treatments, and also for gaining insight into the ferroptosis mechanism.  
 
4.2.2 Synchronous cell-to-cell spreading of ferroptosis 
The phenomenon of the synchronous wave-like death spreading in cell colonies 
undergoing ferroptosis is a very unusual process that is not observed in other types of 
cell death such as apoptosis or necroptosis. This feature of ferroptosis has also been 
observed in ex vivo cultures of renal tubules (Linkermann et al., 2014). The spreading 
of cell death may be dependent on cell contact between neighboring cells and may 
involve the transmission of molecules through gap junctions. Gap junctions are 
intercellular connections of the cytoplasm between cells that allow small molecules, 
ions and calcium to move between cells. Gap junction channels are composed of 
connexin protein subunits and can allow transfer of molecules smaller than 1,000 
daltons (Loewenstein, 1966). Apart from some terminally differentiated cell types, 
such as some nerve cells, skeletal muscle, and circulating lymphocytes, most cells in 
normal tissues form gap junctions. Interestingly, gap junctions have previously been 
implicated in a “bystander effect” occurring mostly during apoptosis, where 
neighboring cells adjacent to those that become damaged can be killed (Feine et al., 
2012; Guo et al., 2014). The bystander effect has been described mostly in the context 
of radiation exposure and treatment with chemotherapy agents, but has also been 
implicated in development processes (Cusato et al., 2003; Prise and O'Sullivan, 2009). 
To examine if gap junctions play a role to spread cell death signals during ferroptosis, 
cells that have been depleted of connexin 43, a commonly expressed and required 
component of gap junctions, can be treated and the synchronous nature of ferroptotic 
cell death can be quantified. Such studies could also be extended to in vivo contexts 
where it will be interesting to examine if ferroptosis can kill cells in trans in mixed 
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tumors, potentially in a gap junction-dependent manner. The inducible knockdown of 
the lipid peroxidase enzyme GPX4, for example, which has been shown to lead to 
ferroptosis induction, may be able to kill control cells within mixed tumors, but not 
when gap junction proteins such as connexin 43 are depleted.  
 
4.2.3 Nutrient uptake of live engulfed cells 
In addition to ferroptosis, I have also investigated the cell death mechanism entosis 
and uncovered regulation controlling apoptosis of live engulfed cells involving the 
amino acid-responsive mTOR kinase pathway within engulfed cells. The mTOR 
kinase exists in two distinct complexes, called mTORC1 and mTORC2, where 
mTORC1 is involved in amino acid sensing and the regulation of mRNA translation 
and autophagy. We have previously shown that entotic cells sometimes undergo death 
by apoptosis (Overholtzer et al., 2007), particularly when autophagy, which likely 
allows for nutrient recycling within engulfed cells, is inhibited. Our findings here 
demonstrate that, to our surprise, the withdrawal of amino acids from culture media 
also induces apoptosis of internalized cells. In conditions of mTOR inhibition or 
knockdown, engulfed cells undergo apoptosis at an increased rate, but if translation is 
kept active, by a knockout of 4E-BP1, engulfed cells are rescued and do not undergo 
apoptosis. This suggests that translation of a certain protein, or proteins, can enable 
live engulfed cells to survive instead of undergoing apoptosis. As mentioned 
previously, anti-apoptotic proteins such as MCL-1 or cFLIP, may be such candidate 
proteins. These data are quite surprising as in a previous study, we have shown that 
most engulfed cells do not have access to growth factors and have decreased mTOR 
activity even in amino acid replete media, consistent with their induction of autophagy 
(Florey et al., 2011). If engulfed cells already have lowered mTOR activity and poor 
access to nutrients, why do these cells undergo apoptosis more often when cultured in 
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amino acid deprived conditions? It may be possible that although engulfed cells have 
decreased mTOR activity compared to control cells, they still retain a threshold that is 
high enough to block apoptosis. Therefore, when mTOR activity is further reduced (by 
mTOR knockdowns or treatment with an mTOR inhibitor), engulfed cells may 
undergo apoptosis more often. This model also suggests that engulfed cells may have 
some degree of access to amino acids, perhaps transiently, that could be responsible 
for sustaining a lowered level of mTOR activity. It is possible that engulfed cells could 
acquire amino acids from the cytosol of host cells directly through gap junctions that 
mediate the transfer of amino acids to internalized cells. Alternatively, it may possible 
that amino acids could reach engulfed cells through vesicle transport from host cells. 
Macropinosomes, for example, have been shown to recycle back to the plasma 
membrane (Hewlett et al., 1994) and we have found evidence that entotic membranes 
retain characteristics of the plasma membrane for extended periods (for hours, or even 
up to more than a day), including localization of E-cadherin and transferrin receptor. It 
is therefore conceivable that endocytc vesicles could “recycle” from host cells to 
engulfed cells by fusing to the entotic membrane that separates them, and in this 
manner engulfed cells could acquire some amount of nutrients, such as amino acids, 
from media. It will be interesting to investigate this hypothesis, potentially by 
imaging-based approaches, to determine if fluorescent media tracers (e.g. labeled 
dextrans) that are internalized into cells by endocytosis or macrpinocytosis can gain 
access to the luminal side of entotic membranes and to engulfed cells.  
 
4.2.4 mTOR-dependent upstream trigger of entotic death 
Another interesting observation arising from my entosis studies is the regulation of the 
non-apoptotic death of engulfed cells involving the amino acid-responsive mTOR 
kinase pathway. We have shown that mTOR activity is required within host cells of 
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cell-in-cell structures for the maturation of entotic vacuoles and subsequent death of 
engulfed cells. The sequence of events that is known to control entotic vacuole 
maturation involves formation of phosphatidylinositol 3-phosphate (PI3P), through 
Vps34 activity, which leads to the recruitment of the Atg12-Atg5-Atg16 autophagy 
protein complex that promotes LC3 lipidation. We have previously shown that 
autophagy pathway proteins participate in entotic cell death by facilitating vacuole 
maturation, and that depletion of the autophagy machinery that controls LC3 lipidation 
also reduces entotic cell death frequencies (Florey et al., 2011). But here we find that 
the regulation of entotic cell death by mTOR is unrelated to its control over 
autophagy, The identity of this secondary, post-engulfment signal that initiates 





The findings discussed here arising from my studies have illuminated two examples of 
crosstalk between nutrient availability and cell survival. Importantly, nutrient 
limitation through amino acid withdrawal influences cell death occurring by multiple 
cell death mechanisms. As the field of cell death continues to expand and a deeper 
understanding of regulated forms of cell death begins to emerge, it will be important to 
consider how these multiple mechanisms may participate together in the context of 
complicated pathologies such as cancer, where nutrients are often limiting and rapid 
cellular evolution also occurs. Cell death occurring over time in complex cancer cell 
populations is likely to proceed through different mechanisms of execution, where 
some regions of solid tumors may undergo forms of regulated necrosis, entosis, or 
apoptosis, perhaps at different times, in manner that is influenced by different nutrient 
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stresses and genetic variation. Entotic cell death for example, which is known to act as 
a mechanism of cell competition, is disrupted to some extent by amino acid starvation 
and may occur through its normal regulation only in regions of tumors where 
mTORC1 is still at least partially active. Ferroptosis, on the other hand, which has 
clear non-cell autonomous activity to spread through cell populations, is promoted by 
amino acid withdrawal. My studies have therefore shown that nutrient availability has 
distinct, and often complex, effects on different modes of cell death, and, further, that 
one particular form, ferroptosis, may be a therapeutic strategy that can be leveraged 
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